title: pauA2 Suppressor_H300_02 in LB

city: Atlanta

first: Yu Chih

last: Peng

state: Georgia

address: 100 Piedmont Ave SE

department: Biology

institute: Georgia State University

description: Gene expression data from pauA2 suppressor H300_02 (ΔpauA2 phoU599)

scan_protocol: Affymetrix Protocol:Scan-M10

organism: Pseudomonas aeruginosa PAO1

source_name: pauA2 suppressor H300_01 in LB

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from approximately 10 ug total RNA

growth_protocol: Overnight grown cultures of P. aeruginosa PAO1 and its derivatives were used to inoculate 10 ml LB broth and grown at 37ºC with shaking at 300rpm.Cells were harvested when the optical density at 600 nm reached 0.4~0.6 by centrifugation for 5 minutes at 4C.

extract_protocol: Total RNA samples were isolated by RNeasy Plus Micro Kit following instructions of the manufacturer (Qiagen). Reverse transcription for cDNA synthesis and fragmentation by DNase I treatment were performed according to the instructions of GeneChip manufacturer (Affymetrix).

treatment_protocol: P. aeruginosa PAO1 was grown in LB broth along.

value: pauA2 suppressor


title: mdx TA replicate 1

status: Public on Oct 01 2016

type: RNA

city: West Lafayette

first: Shihuan

last: Kuang

state: IN

address: 901 W State St

country: USA

institute: Purdue University

description:
raw data file: SG12494259_252800520725_S001_GE2_1105_Oct12_1_1
Biological replicate 1 of 3. mdx TA muscle
mdx-1

hyb_protocol: 300 ng of cRNA from the control and test samples were combined and fragmented at 60°C for 30 minutes in a reaction volume of 25 uL containing 25x Agilent fragmentation buffer and 10x Agilent blocking agent following the manufacturers instructions.  On completion of the fragmentation reaction, 25 uL of 2x Agilent hybridization buffer was added to the fragmentation mixture and hybridized on an Agilent SurePrint G3 mouse 8x60K microarray (028005) 17 hours at 65°C in a rotating Agilent hybridization oven. After hybridization, microarrays were washed 1 minute at room temperature with GE Wash Buffer 1 (Agilent) and 1 minute with 37°C GE Wash buffer 2 (Agilent).

scan_protocol: Scanned on an Agilent SureScan Microarray scanner following manufacturer's protocol.

data_processing: Array image data was extracted using Agilent Feature Extraction Software 11.5 (Agilent Technologies, Santa Clara, CA). Array image data was then uploaded to GeneSpring 12.5 (Agilent Technologies, Santa Clara, CA) for statistical analysis. Microarray analysis was completed with an ANOVA and a Tukey's post-hoc test when a significant ANOVA was observed. In addition, a mean absolute log2 expression ratio of at least 0.585 (50% increase or decrease in expression) must be satisfied.

molecule: total RNA

organism: Mus musculus

source_name: mdx_tibialis anterior muscle

label_protocol: Cy3 (control samples) and Cy5 (test samples) labeled cRNA was prepared using the Agilent LowInput QuickAmp Labeling Kit according to manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.

extract_protocol: Total RNA extracted using Trizol following manufacturer's instructions

treatment_protocol: Mice were all fed on regular chow diet

tag: strain background

tag: mouse model

value: mdx model

tag: genotype/variation

value: mdx

tag: age

value: 9-month old

tag: tissue

value: Tibialis anterior muscle


title: pauA2 Suppressor_H300_01 in LB

description: Gene expression data from pauA2 suppressor H300_01 (ΔpauA2 phoU599)

label: biotin

source_name: pauA2 suppressor H300_02 in LB

tag: strain


title: 9974366108_R04C01

type: genomic

city: OKC

first: Jonathan

middle: Daniel

last: Wren

state: OK

address: 825 NE 13th St

department: Arthritis & Clinical Immunology

institute: Oklahoma Medical Research Foundation

hyb_protocol: Hybridization: 22 hr at 48 degrees C. (full protocol details for all steps can be found in Illumina Infinium HD Methylation Assay manual)

scan_protocol: iScan Scan Setting: Methylation  NXT

data_processing: β values are calculated using the formula:  β = Methylated / (Methylated + Unmethylated + 100). The file methyl_and_unmethylated_signal_Annotated_AA_vs_EA.txt is available on the series record and contains the non-normalized beta values, detection p-values and raw methylated and unmethylated signal in addition to probe annotation.

label: Cy3 and Cy5

molecule: genomic DNA

organism: Homo sapiens

source_name: Naïve CD4+ T cell

label_protocol: Staining Protocol (Tecan Freedom Evo): XStain HD BeadChip

extract_protocol: Whole blood was collected at the time of enrollment and processed within 6 h of collection. Peripheral blood mononuclear cells were isolated using Ficoll density gradient centrifugation media (GE Healthcare Biosciences, USA) followed by indirect isolation of untouched naïve CD4+ T cells using the Naïve CD4+ T cell Isolation Kit II (Miltenyi Biotec Inc., USA). DNA was isolated using the DNeasy Blood and Tissue Kit (Qiagen, USA) and DNA concentration was determined by spectrophotometry on the NanoDrop 2000 (Thermo Scientific, USA). Flow cytometry was used to confirm purity of isolated naïve CD4+ T cells using CD4 and CD45RA fluorochromeconjugated antibodies (BioLegend, USA).

tag: disease state

value: Healthy Control

tag: cell type

value: CD4+ T cell

tag: gender

value: Female

tag: race

value: African-American


title: 9974366089_R04C02

value: European-American


title: 9974366108_R06C02


title: pauA2_H298_02 in LB

description: Gene expression data from pauA2 mutant H298_02 (ΔpauA2)

source_name: pauA2 mutant H298_02 in LB

value: pauA2 mutant


title: 9611518084_R06C02


title: 9611518100_R02C01


title: 9974366089_R06C02


title: 9974366108_R04C02


title: pauA2_H298_01 in LB

description: Gene expression data from pauA2 mutant H298_01 (ΔpauA2)

source_name: pauA2 mutant H298_01 in LB


title: PAO1 H103 WT in LB

description: Gene expression data from PAO1 H103 (wild-type)

source_name: PAO1 H103 WT in LB

value: wild-type


title: 9611518100_R04C02


title: 9611518100_R02C02


title: Sample S29

city: Berlin

first: Raik

last: Otto

state: Berlin

address: Rudower Chaussee 25

department: Computer Science

country: Germany

institute: Humboldt-Universität zu Berlin

description:
HNSCC Patient-derived Xenograft mRNA sample
9897

hyb_protocol: Done by contractor source bioscience (protocol details unknown)

data_processing: R Package affyPLM was used for parsing, background correction with GC-RMA, quantile-normalization and median-polish

label: PDX-sample

source_name: HNSCC Patient-derived Xenograft_CL

growth_protocol: 3rd passage of pdx tumors were harvested from the untreated control group after three weeks of growth and frozen in liquid nitrogen immediately.

extract_protocol: Qiagen Rneasy Protocol

treatment_protocol: Drug treatment lasted for three weeks starting at a tumor size of 100mm3 at the end of treatment tumor was harvested at stored in liquid nitrogen. Tumors subjected to RNA expression analysis were derived from the untreated control group

tag: response to cetuximab

value: responder

tag: molecular subtype

value: CL


title: Sample S28

description:
HNSCC Patient-derived Xenograft mRNA sample
9876

scan_protocol: Done by contractor source bioscience (protocol details unknown)

value: non-responder


title: 9611518082_R06C02


title: 9611518084_R05C02


title: 9611518082_R06C01


title: 9611518074_R02C02


title: 9611518084_R02C01


title: 9611518074_R06C01


title: Sample S22

description:
HNSCC Patient-derived Xenograft mRNA sample
11303

label_protocol: Done by contractor source bioscience (protocol details unknown)


title: Sample S23

description:
HNSCC Patient-derived Xenograft mRNA sample
11437A

source_name: HNSCC Patient-derived Xenograft_BA

value: BA


title: 8942334069_R04C02


title: Mosaic KS patient 2 versus pooled control replicate

city: Chieti

first: Valentina

last: Gatta

state: Abruzzo

address: Via Colle Dell'Ara

department: Department of Psychological SciencesDepartment of Psychological Sciences

country: Italy

institute: University G.d'Annunzio

description: Experiment 2 technical replicate

hyb_protocol: 2 µg of respectively Cy3-Cy5 labeled aRNA, from each patient and control pool, were fragmented and then hybridized on a Phalanx Human OneArray™ V5 using 1.5X OneArray hybridization Buffer at 42°C in oven for 14-16 hrs.

scan_protocol: After hybridization, Cy3-Cy5 fluorescent signals were captured by a Confocal Laser Scanner ScanArray Express (Perkin Elmer, Waltham, MA, USA) and analysed using the software ScanArray Express - MicroArray Analysis System version 3.0 (Perkin Elmer, Waltham, MA, USA). The values of the median signal intensity from each spot were subtracted from the local median background intensity. For each slide after local background subtraction, a LOWESS algorithm was used for row data normalization to evaluate signal to noise ratio and generate log ratios of sample vs. reference signal.

data_processing: A gene was considered to be significantly expressed when showing an absolute value of log-ratio higher or equal to 0.5, an index that translates to a fold-change > 0.7 or < 1.4 in transcript quantity, a present call in at least the 50% of experiments and a p-Value <0.05. False Discovery Rate (FDR) was used to adjust p-values and to correct for the multiple testing issues; FDR was set < 10%. The resulting gene lists underwent a clustering analysis (Cluster 3.0 and TreeView, Stanford University Labs) to unravel Genes Differentially Expressed (DEGs). Identified DEGs were, then, analysed by Ingenuity Pathways Analysis (IPA) software (Ingenuity Systems, Redwood City, CA, USA) to disclose the biological functions and the functional networks they are involved in.

source_name: Testicular biopsy of patient 2 (K2) affected by Mosaic Klinefelter Syndrome

label_protocol: Extracted RNA was linearly amplified using the Amino Allyl MessageAmp™ II aRNA Amplification Kit (Ambion, Austin, TX, USA), following the 2 rounds amplification protocol. 10 to 20 µg of amplified aRNA were fluorescently labeled with Cy3 or Cy5 cyanins.

extract_protocol: Total RNA was extracted from Mosaic KS and control testicular biopsies using the RNeasy Microarray Tissue Mini Kit (Quiagen, Hilden, Germany) after homogenization of the samples, following the manufacturer’s instructions. The RNAs extracted from controls were pooled.

value: male

tag: pathology

value: Mosaic KS Male testicular biopsy

value: oligozoospermia

source_name: Control testicular biopsies from 3 patients with normal spermatogenesis and obstructive infertility

value: obstructive infertilty

value: testicular biopsy


title: Mosaic KS patient 3 versus pooled control replicate

description: Experiment 3 technical replicate

source_name: Testicular biopsy of patient 3 (K3) affected by Mosaic Klinefelter Syndrome


title: 8942334069_R04C01


title: 8942334069_R02C02


title: Sample S27

description:
HNSCC Patient-derived Xenograft mRNA sample
9619


title: Sample S25

description:
HNSCC Patient-derived Xenograft mRNA sample
11452


title: Sample S21

description:
HNSCC Patient-derived Xenograft mRNA sample
11269B


title: 8942334069_R02C01


title: Sample S26

description:
HNSCC Patient-derived Xenograft mRNA sample
11482


title: Sample S24

description:
HNSCC Patient-derived Xenograft mRNA sample
11437B


title: Mosaic KS patient 3 versus pooled control

description: Experiment 3


title: Sample S20

description:
HNSCC Patient-derived Xenograft mRNA sample
11269A


title: Mosaic KS patient 2 versus pooled control

description: Experiment 2


title: 8942334051_R02C01


title: 8942334051_R06C01


title: 8942334051_R06C02


title: Mosaic KS patient 1 versus pooled control replicate

description: Experiment 1 technical replicate

source_name: Testicular biopsy of patient 1 (K1) affected by Mosaic Klinefelter Syndrome


title: 8942334069_R06C01


title: 8942334051_R02C02


title: Sample S17

description:
HNSCC Patient-derived Xenograft mRNA sample
11142


title: Sample S19

description:
HNSCC Patient-derived Xenograft mRNA sample
11218


title: 9611518082_R01C02


title: 8942334069_R06C02


title: 8942326105_R04C01


title: fa6

city: PALO ALTO

first: Li

last: Ye

state: California

address: 1050 Arastradero Rd Bulding B

institute: Stanford University

description: translating mRNA from shock activated mPFC cells

hyb_protocol: Following fragmentation, cRNA were hybridized at 45C on Affymetrix mouse gene expression arrays

scan_protocol: The label, hyb and scan were performed by the Stanford PAN Core facility according to established methods.

data_processing:
Analyzed by Transcriptome Analysis Console.
affymetrix-algorithm-name = rma-gene-full
affymetrix-algorithm-version = 1.0

source_name: shock-activated mPFC

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol.

extract_protocol: Trizonl followed by MicroRNA kit from Qiagen

treatment_protocol: 15mg/kg cocaine for 2 days or 20x2s shocks (0.5mA) for 2 days

tag: protocol

value: shock-activated

value: medial Prefrontal Cortex (mPFC)

tag: ip antibody

value: anti-GFP (ab290, Abcam)


title: fa5


title: fa4


title: 8942334051_R04C02

value: Healthy Control

value: CD4+ T cell

value: Female


title: Sample S16

description:
HNSCC Patient-derived Xenograft mRNA sample
11097


title: Sample S15

description:
HNSCC Patient-derived Xenograft mRNA sample
10980B


title: 8942326105_R04C02

value: European-American


title: Sample S12

description:
HNSCC Patient-derived Xenograft mRNA sample
10927


title: ca6

description: translating mRNA from cocained activated mPFC cells

source_name: cocaine-activated mPFC

value: cocaine-activated


title: ca7


title: 8942334051_R04C01


title: ca5


title: 8942326105_R02C01


title: Sample S13

description:
HNSCC Patient-derived Xenograft mRNA sample
10960

source_name: HNSCC Patient-derived Xenograft_MS

value: responder

value: MS


title: Sample S9

description:
HNSCC Patient-derived Xenograft mRNA sample
10913


title: Sample S10

description:
HNSCC Patient-derived Xenograft mRNA sample
10922


title: Sample S11

description:
HNSCC Patient-derived Xenograft mRNA sample
10924

value: non-responder


title: 7471147162_R05C02


title: Cd bio rep 3

first: Joshua

last: Chandler

address: 615 Michael St

institute: Emory University

hyb_protocol: Biotin labeled cDNA is hybridized at 45 degrees C for 16 hours. Arrays are washed and stained on GeneChip 450 fluidics station with chip-appropriate fluidics script.

scan_protocol: Affymetrix 7G scanner with Command Console software

data_processing: The RMA table was generated with the R package 'oligo'; subsequently 'limma' and the GSEA applet (Broad Institute) were used on these data

source_name: Cd lung tissue

label_protocol: NuGen Encore Biotin labeling

growth_protocol: Acquired for study at 8 weeks age, maintained in controlled veterinary care housing 20 more weeks.

extract_protocol: Samples were snap frozen in liquid N2. RNA was extracted with the mirVana kit using recommended wet mass of lung tissue.

treatment_protocol: 10 mg/L CdCl2 was put in drinking water of Cd-treated mice.

value: 28 weeks

value: Lung


title: 7471147162_R02C01


title: 8942326105_R06C02

value: African-American


title: Sample S8

description:
HNSCC Patient-derived Xenograft mRNA sample
10632


title: 7471147162_R04C01


title: 8942326105_R06C01


title: 7471147162_R02C02


title: ca4


title: Mosaic KS patient 1 versus pooled control

description: Experiment 1

value: male

value: Mosaic KS Male testicular biopsy

value: oligozoospermia


title: Cd bio rep 2


title: 8942326105_R02C02


title: Sample S7

description:
HNSCC Patient-derived Xenograft mRNA sample
10621


title: Control bio rep 3

source_name: Control lung tissue


title: Peripheral Blood_CD8_Control_miRNA_Sample 8

city: Bursa

first: Ferah

last: Budak

address: Gorukle

department: Medical Faculty

country: Turkey

institute: Uludag University

description: microRNA expression in control_sample 8

hyb_protocol: Spike Kit (Agilent, UK) and Agilent microRNA Hybridization Kit (Agilent, UK) were used to hybridize into Human miRNA Microarray, Release 19.0, 8x60K(v19) microarray slides (Agilent, UK)

scan_protocol: Human miRNA Microarray, Release 19.0, 8x60K(v19) microarray slides (Agilent, UK) scanned using Nimblegen MS200 array scanner.

data_processing: The TIFF image files obtained were processed using Agilent Feature Extraction software to extract raw data and obtain QC reports.

source_name: Peripheral Blood

label_protocol: MicroRNAs from RNA samples were marked with Cy3 fluorescent dye while transforming them into cDNA using 100ng RNA Agilent miRNA labeling Kit (Agilent, UK)

extract_protocol: Peripheral blood mononuclear cells (PBMCs) were separated from the 20 ml blood samples obtained from the patients in acute, chronic and healthy control groups via intensity gradient centrifuge method with Ficoll  (Biochrom, Germany). PBMC fraction of patient whole blood was stained using CD4-FITC, CD8 PE, CD3 PerCP (Beckton Dickinson (BD), Biosciences, USA) antibodies to distinguish the CD8+ T cells for FACS. Antibodies were supplied by BD Biosciences, Inc. (USA) and used at the minimal saturating concentration, determined by titration prior to the experiment. PBMCs were stained with the antibody combination for 20 minutes at room temperature, washed twice and resuspended in PBS supplemented with 1% FCS. CD8+ T cells were sorted on FACSAria (BD Biosciences cell-sorter, USA) and kept at 4°C throughout sorting. Live PBMCs were gated based on forward versus scatter profiles, followed by CD3+ based gating for T lymphocyte identification. The CD3+ positive population was subdivided by CD8/CD4 expression and used for the identification of CD8+ (CD4–CD8+) T cells. Purity was determined for CD8+ T cells isolated by FACS for CD8+ T cells (99,8 % purity) Sorted cells were immediately centrifuged and pellets were resuspended in TriPure Isolation Reagent  (Roche, Germany) at -80°C until use.  Cells were stored with TriPure Isolation Reagent  (Roche, Germany) at -80°C until use.  miRNeasy Kit (Qiagen, Germany) was used in accordance with the manufacturer protocol for the total RNA isolation from the isolated CD8+ T cells. The measurements of concentrations and purities were carried out using the Nanodrop (Thermo Scientific, USA) equipment. RNA qualities were determined in Agilent Bioanalyzer (Agilent, UK) device using Agilent RNA 6000 Nano Kit.

value: whole blood

tag: infection

value: control


title: Cd bio rep 1


title: 7471147162_R01C01


title: Peripheral Blood_CD8_Control_miRNA_Sample 6

description: microRNA expression in control_sample 6


title: Sample S3

description:
HNSCC Patient-derived Xenograft mRNA sample
10159

value: BA


title: Peripheral Blood_CD8_Control_miRNA_Sample 7

description: microRNA expression in control_sample 7

value: female


title: 7471147162_R03C01

value: Healthy Control

value: CD4+ T cell


title: Sample S4

description:
HNSCC Patient-derived Xenograft mRNA sample
10309


title: 7471147162_R06C01

value: Female

value: European-American


title: Control bio rep 1


title: Sample S2

description:
HNSCC Patient-derived Xenograft mRNA sample
10114

value: responder

value: CL


title: Peripheral Blood_CD8_Control_miRNA_Sample 5

description: microRNA expression in control_sample 5


title: 7471147162_R03C02


title: Sample S1

description:
HNSCC Patient-derived Xenograft mRNA sample
10110


title: 7471147162_R01C02


title: Sample S18

description:
HNSCC Patient-derived Xenograft mRNA sample
11143


title: Control bio rep 2


title: Peripheral Blood_CD8_Control_miRNA_Sample 4

description: microRNA expression in control_sample 4


title: PA3-orf70.1/Lysates_Stb_rep1

city: ChongQing

first: Xia

last: Zhao

address: Shapingba

country: China

institute: Third military medical school

description: Gene expression with gp70.1 at stable phase

hyb_protocol: Ribobio gene Hybridization Protocol

scan_protocol: Slides were scanned by Agilent Microarray Scanner (Cat#G2565BA, Agilent )  technologies, Santa Clara, CA, US) and Feature Extraction software 10.7 (Agilent   technologies, Santa Clara, CA, US) with default settings，Scan resolution=5μm, PMT   100%，10%.

data_processing: Raw signals were normalized with subtract background correction and quantile normalization method. Normalized intensities were transformed to gene expression log2 value. Ratio and log2 ratio of normalized spot intensites between test sample and control sample were calculated. The p-values are calculated with ANOVA Method(O'Mahony, Michael (1986). Sensory Evaluation of Food: Statistical Methods and Procedures. CRC Press. pp. 487. ISBN 0-8247-7337-3). It means the probability of control sample and test sample are no differential expression. So, if p-value (Differentially expressed) is greater than thethreshold it means no differential expression was observed.

organism: Pseudomonas aeruginosa

source_name: PA3/pUCP24-orf70.1, stable phase

label_protocol: Labeling efficiency can be calculated by the concentration of CyDye and RNA measured by K5500 micro-spectrophotometer. For good microarray result, labeling efficiency should be between 1.0~3.6.

growth_protocol: PA3 was grown in Luria-Bertani (LB) broth medium aerobically.

extract_protocol: Total RNA was isolated using SV Total RNA Isolation System (Promega) according to the manufacturer’s instructions and   checked for a RIN number to inspect RNA integration by an Agilent Bioanalyzer

treatment_protocol: PA3 were  electrotransformed with pUCP24 (control) or PA3/pUCP24-orf70.1.

tag: phage protein

value: PaP3 protein

tag: growth phase

value: stable phase


title: PA3-orf70.1/Lysates_Stb_rep2


title: Peripheral Blood_CD8_Control_miRNA_Sample 3

description: microRNA expression in control_sample 3


title: 6929726159_R06C02

source_name: Naïve CD4+ T cell


title: 6929726159_R01C02


title: PA3-orf70.1/Lysates_Log_rep2

description: Gene expression with gp70.1 at logarithmic phase

source_name: PA3/pUCP24-orf70.1, logarithmic phase

value: logarithmic phase


title: 6929726159_R02C02


title: PA3-orf70.1/Lysates_Log_rep3


title: PA3-orf70.1/Lysates_Log_rep1


title: PA3-orf70.1/Lysates_Stb_rep3


title: Peripheral Blood_CD8_Control_miRNA_Sample 1

description: microRNA expression in control_sample 1


title: Fbxl19_Knockdown_shRNA2_rep2

city: Austin

first: Bum-Kyu

last: Lee

state: TX

address: 2506 Speedway Stop A5000

institute: University of Texas at Austin

description: Gene expression data upon KD of Fbxl22

hyb_protocol: A hybridization mixture including the fragmented DNA and probe array controls were prepared, and then hybridized to the probe array   during a 16-hour incubation

scan_protocol: GeneChips were scanned by Scanner 3000, Affymetrix

data_processing: Robust multi-array (RMA) normalization method was applied to calculate averaged expression values from replicates

label_protocol: cDNAs were generated using qScript (Qunta) and then labeled with Cy3

growth_protocol: Mouse J1 ES cells were cultivated in 0.1% gelatin coated dishes using DMEM (Dulbecco’s modified Eagle’s medium) supplemented with 20% fetal bovine serum (FBS), 2 mM of L-glutamine, 0.1 mM of non-essential amino acid, 1% of nucleoside mix, 0.1 mM of ß-mercaptoethanol, 1000U/ml of recombinant leukemia inhibitory factor and 50 U/ml of Penicillin/Streptomycin.

extract_protocol: Total RNAs were extracted using RNeasy plus mini kit (Qiagen)

tag: cell line

value: ES


title: Peripheral Blood_CD8_Control_miRNA_Sample 2

description: microRNA expression in control_sample 2

value: male


title: Fbxl19_Knockdown_shRNA1_rep2

description: Gene expression data upon KD of Fbxl20


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 7

description: microRNA expression in chronic brucella infection_sample 7

value: chronic brucella


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 6

description: microRNA expression in chronic brucella infection_sample 6


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 8

description: microRNA expression in chronic brucella infection_sample 8


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 4

description: microRNA expression in chronic brucella infection_sample 4


title: Fbxl19_Knockdown_shRNA1_rep1

description: Gene expression data upon KD of Fbxl19


title: PA3-orf70.1/Lysates_Lag_rep2

description: Gene expression with gp70.1 at lag phase

source_name: PA3/pUCP24-orf70.1, lag phase

value: lag phase


title: 6929726159_R04C02

value: African-American


title: Fbxl19_Knockdown_shRNA2_rep1

description: Gene expression data upon KD of Fbxl21


title: 6929726159_R03C02


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 5

description: microRNA expression in chronic brucella infection_sample 5

value: whole blood


title: differentiated_d4_replicate2

description: Gene expression data after differentiation day4

source_name: embryonic stem cells_differentiated_d4


title: 6929726159_R05C02


title: Control/Lysates_Stb_rep3

description: Gene expression with empty plasmid control at stable phase

source_name: PA3/pUCP24 lysates, stable phase

value: control (empty plasmid)


title: PA3-orf70.1/Lysates_Lag_rep1


title: Control/Lysates_Stb_rep2


title: Control/Lysates_Stb_rep1


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 3

description: microRNA expression in chronic brucella infection_sample 3

value: female


title: ID_10

city: Amsterdam

first: Esther

last: Lips

address: Plesmanlaan 121

department: Molecular Pathology

country: Netherlands

institute: NKI-AVL

hyb_protocol: Hybridisation as described in: Joosse et al. (Br Can Res Tr, 2009)

scan_protocol: Scanning as described in: Joosse et al. (Br Can Res Tr, 2009)

data_processing:
Data processing of the scanned microarray slide included signal intensity measurement with the ImaGene software program, followed by median pin-tip (c.q. ubarray) normalization. Intensity ratios (Cy5/Cy3) were log2-transformed and triplicate spot measurements were averaged.
Intensity ratios (Cy5/Cy3) were log2-transformed and triplicate spot measurements were averaged.

source_name: breast tumor

label_protocol: Labeling is performed as described in: Joosse et al. (Br Can Res Tr, 2009)

extract_protocol: DNA is extracted as described in: Joosse et al. (Br Can Res Tr, 2009)

tag: tumor type

value: invasive breast cancer

tag: age (yrs)

tag: histology

value: IDC (invasive ductal carcinoma)

tag: grade

value: ND

value: neg

source_name: normal female DNA

tag: sample type

value: Promega normal female reference DNA

tag: catalog number


title: Control/Lysates_Log_rep3

description: Gene expression with empty plasmid control at logarithmic phase

source_name: PA3/pUCP24 lysates, logarithmic phase


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 1

description: microRNA expression in chronic brucella infection_sample 1

tag: tissue

tag: gender

tag: age


title: differentiated_d4_replicate1

tag: cell type


title: shControl_replicate2

description: Gene expression data upon control KD

source_name: embryonic stem cells_shControl


title: ID_7

value: ILC (invasive lobular carcinoma)


title: shControl_replicate1

description: Gene expression data upon control KD


title: ID_5


title: Control/Lysates_Log_rep2


title: Sample S5

description:
HNSCC Patient-derived Xenograft mRNA sample
10379

source_name: HNSCC Patient-derived Xenograft_BA

tag: response to cetuximab

value: responder

tag: molecular subtype

value: BA


title: Peripheral Blood_CD8_Acute Brucellosis_miRNA_Sample 7

description: microRNA expression in acute brucella infection_sample 7

value: acute brucella


title: Peripheral Blood_CD8_Acute Brucellosis_miRNA_Sample 5

description: microRNA expression in acute brucella infection_sample 5


title: Control/Lysates_Log_rep1

value: logarithmic phase


title: Peripheral Blood_CD8_Chronic Brucellosis_miRNA_Sample 2

description: microRNA expression in chronic brucella infection_sample 2


title: Control/Lysates_Lag_rep3

description: Gene expression with empty plasmid control at lag phase

source_name: PA3/pUCP24 lysates, lag phase


title: Control/Lysates_Lag_rep2


title: PA3-orf70.1/Lysates_Lag_rep3

value: PaP3 protein


title: Control/Lysates_Lag_rep1


title: Sample S6

description:
HNSCC Patient-derived Xenograft mRNA sample
10511


title: Peripheral Blood_CD8_Acute Brucellosis_miRNA_Sample 6

description: microRNA expression in acute brucella infection_sample 6

value: male


title: Peripheral Blood_CD8_Acute Brucellosis_miRNA_Sample 4

description: microRNA expression in acute brucella infection_sample 4


title: Peripheral Blood_CD8_Acute Brucellosis_miRNA_Sample 3

description: microRNA expression in acute brucella infection_sample 3


title: Peripheral Blood_CD8_Acute Brucellosis_miRNA_Sample 2

description: microRNA expression in acute brucella infection_sample 2


title: 7471147162_R06C02

tag: disease state

value: Healthy Control

value: CD4+ T cell

value: Female

tag: race

value: European-American


title: Liver_GMO rep9

city: London

first: Matthew

last: Arno

state: LONDON

address: 150 Stamford Street

department: Genomics Centre

country: United Kingdom

institute: King's College London

hyb_protocol: Hybridisation cocktails were prepared using 5.5ug cDNA as described in the Eukaryotic Array manual from Affymetrix, using the Hybridisation, Wash and Stain (HWS) kit (Affymetrix)

scan_protocol: Arrays were scanned using the GCS3000 7G scanner (Affymetrix) following manufacturer's protocols.

data_processing: CEL files were imported into Expression Console software (Affymetrix) and normalised using RMA-sketch (gene-level).

label: Biotin

organism: Rattus norvegicus

label_protocol: RNA was processed using the Ambion WT Expression kit and Affymetrix WT Terminal Labelling kit.

extract_protocol: Frozen liver samples were homogenised and RNA extracted using MagMAX-96 for Micorarrays Kit (AM1839). The spin procedure was followed. RNA was eluted in 50ul of elution buffer.

treatment_protocol: Livers were extracted at autopsy and half of the organ was snap frozen for RNA subsequent RNA isolation. Samples were stored at -80 until extraction.

value: female

tag: strain

value: Sprague-Dawley

value: Liver

tag: experimental group

value: GMO

tag: age at death (days)


title: mouse 2632, Homozygous

city: Aurora

first: Jennifer

middle: K

last: Richer

state: CO

address: Mail Stop 8104, RC1N 5th Floor P18-5127, 12800 E. 19th Ave.

department: Pathology

institute: University of Colorado Anschutz Medical Campus

hyb_protocol: One ug of biotinylated RNA from each sample was hybridized onto Affymetrix® GeneChip Mouse Transcriptome Array 1.0 according to the manufacturer's recommendations.

scan_protocol: GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.

data_processing: Affymetrix CEL files from all samples hybridized to the mRNA arrays were loaded on to Genespring GX10. Signal intensities for all probe sets were obtained using Robust Multichip Averaging summarization algorithm which involves three steps - background correction, quantile normalization and probe summarization (median polish). Quality control was performed by principal component analysis to identify outliers. Low intesity probe sets below 20 percentile were filtered prior to statistical analysis.

source_name: L2 MECs with constitutive expression of miR-150.

label_protocol: One ug of total RNA from each sample was labelled with FlashTag Biotin RNA Labeling kit (Genisphere, Hatfield, PA, USA).

growth_protocol: At 8 weeks old, female mice were impregnated by WAP-Cre- males. Lactation day 1 was identified as the first day litters were present and tissue was harvested on lactation day 2.

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

treatment_protocol: Adipose-depleted mouse mammary epithelial cells were isolated from the upper inguinal mammary glands as described in (Rudolph et al., 2009).

tag: strain background

value: mixed (C57BL6 and FVB)

tag: genotype/variation

value: Stop-150fl/fl; WAP-Cre+

value: lactation day 2 (L2; 65 days old)

value: mammary epithelial cells (MECs)


title: mouse 2691, Homozygous

value: lactation day 2 (L2; 67 days old)


title: Liver_GMO rep4


title: Non diabetic foot fibroblasts sample 23

city: MIAMI

first: Marjana

last: Tomic-Canic

address: 1600 SW 10th Ave, RMSB RM2029A

institute: University of Miami

description: Nanostring probes

data_processing:
The miRNA data were all normalized to housekeeping genes included in the assays
the values shown in the Matrix normalized template are values normalized to houskeeping genes included in the assays. The fold change values in the Fold change template sheet are expressed as Fold change(DFUF/NFF)

source_name: nanostring data generated from RNA isolated from primary fibroblasts generated from a non-diabetic foot skin biopsy

label_protocol: 100ng of total RNA was used for sample preparation for the nanoString nCounter assay according to the Nanostring protocols.

growth_protocol: foot skin biopsies obtained from diabetic and non-diabetic people were thoroughly washed in DMEM supplemented with 2× Penicillin/Streptomycin/Fungizone, and gentamicin (50mg/L). After, the epidermis was removed from specimens, the dermis was finely minced and placed in 12-well plates. For the establishment of fibroblast cultures, DMEM (Life Technologies) supplemented with 10% FBS, HEPES (1.9mg/ml), streptomycin (100 μg/ml), penicillin (100 U/ml), and Fungizone Antimycotic (0.25 µg/mL) was used

extract_protocol: Total RNA was isolated from cells (passage 4) using miRNeasy Mini Kit (QIAGEN)

value: Non diabetic foot fibroblasts


title: mouse 2795, Homozygous

value: lactation day 2 (L2; 80 days old)


title: Peripheral Blood_CD8_Acute Brucellosis_miRNA_Sample 1

description: microRNA expression in acute brucella infection_sample 1

value: whole blood

tag: infection

value: acute brucella


title: Liver_GMO rep8


title: ACC 1h_rep3

city: WINSTON SALEM

first: Gloria

middle: Kressin

last: Muday

state: North Carolina

address: 1834 Wake Forest Road

institute: Wake Forest University

description:
ACC1_3
gene expression data from 6 day old arabidopsis roots

hyb_protocol: Following fragmentation, 20 ug of labeled cRNA was hybridized for 16 hr at 45 degrees C on the Affymetrix GeneChips. GeneChips were washed and stained using the GeneChip 450 Fluidics Station according to standard Affymetrix operating procedures

scan_protocol: GeneChips were scanned using the GeneChip Scanner 3000 7G system according to the standard Affymetrix protocol

data_processing: Raw data were normalized using systematic variation normalization, and the log2 of the signal intensity is reported.

organism: Arabidopsis thaliana

source_name: 6 day old roots placed on auxin medium for 1 hour

label_protocol: Approximately 5ug of purified total RNA was processed to produce biotinylated cRNA targets followed by streptavidin-phycoerythrin fluorescent staining according to the standard Affymetrix 3’-IVT labeling protocol

growth_protocol: 6 days of growth in 100 umol/m2sec2 continuous cool white light on a nylon screen (03-100/32; Sefar Filtration) pressed tightly against 1xMS 1% sucrose media (pH 5.6)

extract_protocol: Root samples were ground in liquid nitrogen and the RNA was extracted using the Qiagen Plant RNeasy kit.  The RNA was then precipitated from the eluate with isopropanol

treatment_protocol: Nylon mesh with seedlings was transferred to a fresh control media or media containing 1 uM ACC at time 0

tag: agent

value: auxin medium

tag: time

value: 1 hour

tag: developmental stage

value: seedling

value: 6 days old

value: root


title: mouse 2882, Control

source_name: control L2 MECs.

value: Stop-150-; WAP-Cre+

value: lactation day 2 (L2; 78 days old)

tag: tissue


title: control 12h_rep3

description:
c12_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for 12 hours

value: control medium

value: 12 hours


title: control 8h_rep3

description:
c8_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for 8 hours

value: 8 hours


title: Liver_GMO rep3

tag: gender

value: female

value: Sprague-Dawley

value: Liver

value: GMO


title: Liver_GMO rep5


title: mouse 2634, Control

value: mixed (C57BL6 and FVB)

tag: age

value: lactation day 2 (L2; 79 days old)

value: mammary epithelial cells (MECs)


title: Liver_GMO rep6


title: mouse 2633, Homozygous

value: Stop-150fl/fl; WAP-Cre+

value: lactation day 2 (L2; 65 days old)


title: Liver_GMO+R rep9

value: GMO+R


title: Liver_GMO rep7


title: control 24h_rep3

description:
c24_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for 24 hours

value: 24 hours

value: seedling

value: 6 days old


title: Liver_GMO rep2


title: Liver_GMO rep1


title: control 2h_rep3

description:
c2_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for 2 hours

value: 2 hours

value: root


title: mouse 2790, Control

value: Stop-150-; WAP-Cre+

value: lactation day 2 (L2; 77 days old)


title: control 4h_rep3

description:
c4_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for 4 hours

value: control medium

value: 4 hours


title: mouse 2779, Control

value: lactation day 2 (L2; 86 days old)


title: ID_13

description: Sample 13

hyb_protocol: According to manufacterer's protocol (Nimblegen Roche)

scan_protocol: 2 um double pass

data_processing:
The resulting image files were further analyzed using NimbleScan software (Roche Nimblegen). Grids were aligned on the picture manually and per channel pair files generated (raw data). The Nimblescan DNACopy algorithm was applied at default settings and the unaveraged DNAcopy text files were used for further analyses.
Nimblescan, grid tiff files, generate pair reports followed by using the NimbleScan DNAcopy procedure at default settings. Finally log2 ratios (test/reference) were obtained using Nimblescan default settings (included in sample data table)

source_name: ER-positive BRCA1-mutated breast cancers

label_protocol: With the ENZO 42760 labeling kit for array CGH: 20 uL primers (vial 1) with 500 ng of genomic tumor DNA or Promega Female reference DNA (GG1521) in 19 ul of nuclease free water for 10 minutes at 99 C in pcr machine, followed by 10 minutes of cooling to 4 degrees. Snap freeze and spin. While on ice add 11 ul Cy3 mix (10ul Cy3+1ul Klenow DNA pol (vial 4)) to tumor DNA, and 11 ul Cy5 mix (10ul Cy3+1ul Klenow DNA pol (vial 4)) to reference DNA and incubate in PCR machine for 4 hours at 37 C. Then add 5ul stop buffer (vial 5).  To remove excess nucleotides with Qiagen MinElute PCR purification kit add 275 uL binding buffer (PB) to sample and reference. Put on minElute column and spin 60 sec on 16000 rcf. Add 700 ul Wash Buffer (PE) and centrifuge 60 secs at 16000 rcf. Dry columns by spinning another 60 secs at 16000 rcf. Elute the DNA in 2 steps by adding 2x 10.5 ul of elution buffer (EB). Pool equal amounts of tumor and reference DNA and speedvac into a pellet.

extract_protocol: 10 x 10 u slices containing at least 60% tumour cells were cleared of paraffin (2 x 5 min xylene, 2 x 30 s 100% ethanol, 30s 90% ethanol, 30 s 70% ethanol, and rinsed with H2O), treated with 1 M NaSCN at 37 C overnight, and sections of interest (>70% tumour cells) were scraped in 200 ul buffer ATL (Qiagen, cat. no. 51304).  27 ul of proteinase K (15 ug/ull, Roche, cat. no.3115879001) was immediately added, as well as at the end of the day, and at the beginning and end of the next day; samples were constantly shaken at 37 C during the time of digestion. The following day, 40 ul RNase A (20 ug/ul, Sigma, cat. no. R5500) was added to the sample, vortexed, and incubated for 2 min at room temperature. 400 ul of buffer AL (Qiagen, cat.no.51304) was added and incubated for 10 min at 70 C. 420 ul of 100% ethanol was added and vortexed. The sample mixture was spun on a spincolumn (Qiagen, cat. no. 51304) for 1 min at 8,000 rpm. The column was sequentially washed with 500 ul of the following reagents and spun for 1 min at 8,000 rpm: AW1, AW2, and  twice with 80% ethanol. The column was spun dry for 3 min at 14,000 rpm. The sample was eluted with 50 ul of AE buffer by spinning for 1 min at 8,000 rpm.  (Joosse, SA et al, Breast Cancer Res Treat, 2009)

tag: age (yrs)

tag: tumor type

value: invasive breast cancer

tag: histology

value: IDC (invasive ductal carcinoma)

tag: grade

value: neg

tag: sample type

value: Promega normal female reference DNA

tag: catalog number


title: ID_12

description: Sample 12

value: pos


title: Non diabetic foot fibroblasts sample 14

description: Nanostring probes

tag: cell type

value: Non diabetic foot fibroblasts


title: Non diabetic foot fibroblasts sample 12

description: Nanostring probes


title: Diabetic foot ulcer fibroblasts sample 21

description: Nanostring probes

source_name: nanostring data generated from RNA isolated from primary fibroblasts generated from a diabetic foot ulcer biopsy

value: Diabetic foot ulcer fibroblasts


title: Diabetic foot ulcer fibroblasts sample 25

description: Nanostring probes


title: Diabetic foot ulcer fibroblasts sample 8

description: Nanostring probes


title: Liver_GMO+R rep8

value: female

tag: strain

value: Sprague-Dawley

value: Liver

tag: experimental group

value: GMO+R

tag: age at death (days)


title: ID_9

description: Sample 11

value: ND


title: 7471147162_R05C01

source_name: Naïve CD4+ T cell

tag: disease state

value: Healthy Control

value: CD4+ T cell

value: Female

tag: race

value: European-American


title: Liver_GMO+R rep6


title: control 1h_rep3

description:
c1_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for 1 hour

tag: agent

value: control medium

tag: time

value: 1 hour

value: seedling

value: 6 days old

value: root


title: Liver_GMO+R rep7

tag: tissue


title: control 0h_rep3

description:
c0.0_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for <5 minutes

value: <5 minutes

tag: developmental stage


title: ID_11

description: Sample 10

value: invasive breast cancer

value: IDC (invasive ductal carcinoma)

value: neg

source_name: normal female DNA

value: Promega normal female reference DNA


title: control .5h_rep3

description:
c0.5_3
gene expression data from 6 day old arabidopsis roots

source_name: 6 day old roots placed on control medium for 30 minutes

value: 30 minutes

tag: age


title: ID_8

description: Sample 9

tag: age (yrs)


title: Liver_GMO+R rep2

tag: gender

value: female

value: Sprague-Dawley

value: Liver

value: GMO+R


title: Liver_GMO+R rep3


title: Liver_GMO+R rep4


title: Liver_GMO+R rep1


title: ID_4

description: Sample 8

tag: tumor type

tag: histology

value: Mixed


title: ID_1

description: Sample 5

tag: grade

tag: sample type


title: Liver_Control rep10

value: control


title: Liver_GMO+R rep5


title: ID_2

description: Sample 4

tag: catalog number


title: ID_6

description: Sample 3

value: ND


title: ID_16

description: Sample 2


title: ID_14

description: Sample 1


title: Liver_Control rep7

tag: strain


title: control 24h_rep2

description:
c24_2
gene expression data from 6 day old arabidopsis roots

value: control medium

value: 24 hours


title: ID_3

description: Sample 6


title: Liver_Control rep6

tag: experimental group


title: control 2h_rep2

description:
c2_2
gene expression data from 6 day old arabidopsis roots

value: 2 hours

value: seedling

value: 6 days old


title: Liver_Control rep9

tag: age at death (days)


title: Liver_Control rep5


title: Liver_Control rep8


title: Liver_Control rep3


title: Liver_Control rep4


title: control 1h_rep2

description:
c1_2
gene expression data from 6 day old arabidopsis roots

value: 1 hour

value: root


title: Kidney_GMO rep9

extract_protocol: Frozen kidney samples were homogenised and RNA extracted using MagMAX-96 for Micorarrays Kit (AM1839). The spin procedure was followed. RNA was eluted in 50ul of elution buffer.

treatment_protocol: Kidneys were extracted at autopsy and half of the organ was snap frozen for RNA subsequent RNA isolation. Samples were stored at -80 until extraction.

value: Kidney

value: GMO


title: control 12h_rep2

description:
c12_2
gene expression data from 6 day old arabidopsis roots

value: 12 hours


title: ID_15

description: Sample 7

value: invasive breast cancer

value: IDC (invasive ductal carcinoma)

value: neg

value: Promega normal female reference DNA


title: Kidney_GMO rep5

value: female

value: Sprague-Dawley


title: Kidney_GMO rep7


title: control 4h_rep2

description:
c4_2
gene expression data from 6 day old arabidopsis roots

value: 4 hours


title: Liver_Control rep1

value: Liver

value: control


title: control 8h_rep2

description:
c8_2
gene expression data from 6 day old arabidopsis roots

value: control medium

value: 8 hours


title: Kidney_GMO rep8


title: control 0h_rep2

description:
c0.0_2
gene expression data from 6 day old arabidopsis roots

value: <5 minutes

value: seedling

value: 6 days old


title: Kidney_GMO rep4

value: Kidney


title: Kidney_GMO rep2

value: GMO


title: Liver_Control rep2


title: Kidney_GMO rep3


title: control .5h_rep2

description:
c0.5_2
gene expression data from 6 day old arabidopsis roots

value: 30 minutes

value: root


title: Kidney_GMO+R rep9

value: GMO+R


title: Kidney_GMO rep1


title: Kidney_GMO+R rep8


title: control 24h_rep1

description:
c24_1
gene expression data from 6 day old arabidopsis roots

value: 24 hours


title: Kidney_GMO+R rep7


title: control 12h_rep1

description:
c12_1
gene expression data from 6 day old arabidopsis roots

value: 12 hours


title: control 8h_rep1

description:
c8_1
gene expression data from 6 day old arabidopsis roots


title: Kidney_GMO+R rep3

value: female


title: control 1h_rep1

description:
c1_1
gene expression data from 6 day old arabidopsis roots

value: 1 hour


title: Kidney_GMO+R rep4

value: Sprague-Dawley


title: control .5h_rep1

description:
c0.5_1
gene expression data from 6 day old arabidopsis roots


title: Kidney_GMO+R rep6


title: control 4h_rep1

description:
c4_1
gene expression data from 6 day old arabidopsis roots

value: 4 hours


title: Kidney_GMO+R rep2


title: Kidney_GMO+R rep5


title: Kidney_Control rep8

value: control


title: control 2h_rep1

description:
c2_1
gene expression data from 6 day old arabidopsis roots

value: control medium

value: 2 hours


title: Kidney_Control rep7


title: control 0h_rep1

description:
c0.0_1
gene expression data from 6 day old arabidopsis roots

value: <5 minutes


title: Kidney_Control rep9


title: Kidney_GMO+R rep1


title: Kidney_Control rep6


title: Kidney_Control rep3


title: Kidney_Control rep4


title: Control rep 1

city: Daejeon

first: Boyoung

address: 141 Gajeong-ro Yuseong-gu

country: South Korea

institute: Korea Research Institute of Chemical Technology

hyb_protocol: Fragmented and labeled cRNA were hybridized on ATH1 chip. GeneChips were washed and stained according to the Affymetrix protocol.

scan_protocol: GeneChips were scanned using the Hewlett-Packard GeneArray Scanner

data_processing: The expression levels were normalized by global scaling using GenPlex software. The MAS5 algorithm was used for expression summary and signal calculation.

source_name: Right after the bacterial RNA infiltraion

label_protocol: Biotinylated cDNA were prepared according to the standard Affymetrix protocol

growth_protocol: The plants were grown on soilless potting medium (Punong Co. Ltd., Gyeongju, South Korea) at 23ºC in a growth chamber under an 8 h light/16 h dark cycle.

extract_protocol: Total RNA were isolated from ground leaves using Rneasy Plant Mini Kit (Qiagen)

treatment_protocol: With a needleless syringe, bacterial RNA (150 ng/µl) was infiltrated into 4-week-old Arabidopsis leaves

tag: ecotype

tag: stress

value: shoot part of the plant


title: Kidney_Control rep10


title: bacterial RNA infiltration rep 1

source_name: 6h post the bacterial RNA infiltration

value: bacterial RNA infiltration

value: 6 hr


title: Kidney_Control rep2

value: Kidney


title: Ov_Tumor_Reference_Mix vs.  X1325402497

status: Public on Sep 30 2016

city: Santa Monica

first: Habib

last: Hamidi

state: CA

address: 2825 Santa Monica Blvd., Suite 200

institute: UCLA

description: reference_mix: The reference mix contained equal amounts of 106 ovarian samples including the following histologies: adenocarcinama=1, benign=4, clear cell= 3, endothelial=5, goblet cell=1, MMMT=5, mucinous=3. normal=7, serous=67, squamous=1, transitional

hyb_protocol: 825 ng each of labeled reference mix (cy3 label) and individual sample (cy5 label) were applied to Whole Human Genome 4X44 microarrays (Agilent G4112F) using the In Situ Hybridization Kit Plus (Agilent) protocol

scan_protocol: Slides were read on an Agilent G2505B scanner. All experiments were scanned with extended dynamic range enabled.

data_processing:
Agilent Feature Extraction Software (v9.5.1, 10.7, and 11.0) was used with no background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, error model used to determine
Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1 (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method.

source_name: 106 pooled ovarian samples

label_protocol: RNA were labeled with Cy3-CTP or Cy5-CTP using the Quick-Amp Labeling Kit (Agilent) following manufacturer's instructions

extract_protocol: Total RNA extracted using Qiagen RNeasy Kit following manufacturer's protocol.

value: ovary

tag: control type

value: pooled reference sample

source_name: Ovarian Cancer Sample X1325402497


title: Ov_Tumor_Reference_Mix vs.  X1325402458

source_name: Ovarian Cancer Sample X1325402458


title: Ov_Tumor_Reference_Mix vs.  X1325402505

source_name: Ovarian Cancer Sample X1325402505


title: Kidney_Control rep1


title: Kidney_Control rep5


title: Ov_Tumor_Reference_Mix vs.  X1325402506

source_name: Ovarian Cancer Sample X1325402506


title: Ov_Tumor_Reference_Mix vs.  X1325402462

source_name: Ovarian Cancer Sample X1325402462


title: Ov_Tumor_Reference_Mix vs.  X1325402477

source_name: Ovarian Cancer Sample X1325402477


title: Ov_Tumor_Reference_Mix vs.  X1325402500

source_name: Ovarian Cancer Sample X1325402500


title: Ov_Tumor_Reference_Mix vs.  X1325402496

source_name: Ovarian Cancer Sample X1325402496


title: Ov_Tumor_Reference_Mix vs.  X1325402501

source_name: Ovarian Cancer Sample X1325402501


title: Ov_Tumor_Reference_Mix vs.  X1325402488

source_name: Ovarian Cancer Sample X1325402488


title: Ov_Tumor_Reference_Mix vs.  X1325402461

source_name: Ovarian Cancer Sample X1325402461


title: Ov_Tumor_Reference_Mix vs.  X1325402508

source_name: Ovarian Cancer Sample X1325402508


title: Ov_Tumor_Reference_Mix vs.  X1325402468

source_name: Ovarian Cancer Sample X1325402468


title: Ov_Tumor_Reference_Mix vs.  X1325402457

source_name: Ovarian Cancer Sample X1325402457


title: Ov_Tumor_Reference_Mix vs.  X1325402491

source_name: Ovarian Cancer Sample X1325402491


title: Ov_Tumor_Reference_Mix vs.  X1325402510

source_name: Ovarian Cancer Sample X1325402510


title: Ov_Tumor_Reference_Mix vs.  X1325402479

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1325402479


title: Ov_Tumor_Reference_Mix vs.  X1325402478

source_name: Ovarian Cancer Sample X1325402478


title: Ov_Tumor_Reference_Mix vs.  X1325402487

source_name: Ovarian Cancer Sample X1325402487


title: Ov_Tumor_Reference_Mix vs.  X1325402470

source_name: Ovarian Cancer Sample X1325402470


title: Ov_Tumor_Reference_Mix vs.  X1325402493

source_name: Ovarian Cancer Sample X1325402493


title: Ov_Tumor_Reference_Mix vs.  X1325402483

source_name: Ovarian Cancer Sample X1325402483


title: Ov_Tumor_Reference_Mix vs.  X1325402465

source_name: Ovarian Cancer Sample X1325402465


title: Ov_Tumor_Reference_Mix vs.  X1325402507

source_name: Ovarian Cancer Sample X1325402507


title: Ov_Tumor_Reference_Mix vs.  X1325402494

source_name: Ovarian Cancer Sample X1325402494


title: Ov_Tumor_Reference_Mix vs.  X1325402502

source_name: Ovarian Cancer Sample X1325402502


title: Ov_Tumor_Reference_Mix vs.  X1325402482

source_name: Ovarian Cancer Sample X1325402482


title: Ov_Tumor_Reference_Mix vs.  X1325402499

source_name: Ovarian Cancer Sample X1325402499


title: Ov_Tumor_Reference_Mix vs.  X1133902881

source_name: Ovarian Cancer Sample X1133902881


title: Kidney_GMO rep6

value: GMO


title: Ov_Tumor_Reference_Mix vs.  X1325402485

source_name: Ovarian Cancer Sample X1325402485


title: Ov_Tumor_Reference_Mix vs.  X1325402460

source_name: Ovarian Cancer Sample X1325402460


title: Ov_Tumor_Reference_Mix vs.  X1325402475

source_name: Ovarian Cancer Sample X1325402475


title: Ov_Tumor_Reference_Mix vs.  X1325402469

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1325402469


title: Ov_Tumor_Reference_Mix vs.  X1325402455

source_name: Ovarian Cancer Sample X1325402455


title: Ov_Tumor_Reference_Mix vs.  X1325402476

source_name: Ovarian Cancer Sample X1325402476


title: Ov_Tumor_Reference_Mix vs.  X1325402473

source_name: Ovarian Cancer Sample X1325402473


title: Ov_Tumor_Reference_Mix vs.  X1325402459

source_name: Ovarian Cancer Sample X1325402459


title: Ov_Tumor_Reference_Mix vs.  X1325402467

source_name: Ovarian Cancer Sample X1325402467


title: Ov_Tumor_Reference_Mix vs.  X1325402489

source_name: Ovarian Cancer Sample X1325402489


title: Ov_Tumor_Reference_Mix vs.  X1325402503

source_name: Ovarian Cancer Sample X1325402503


title: Ov_Tumor_Reference_Mix vs.  X1325402495

source_name: Ovarian Cancer Sample X1325402495


title: Ov_Tumor_Reference_Mix vs.  X1325402504

source_name: Ovarian Cancer Sample X1325402504


title: Ov_Tumor_Reference_Mix vs.  X1325402492

source_name: Ovarian Cancer Sample X1325402492


title: Ov_Tumor_Reference_Mix vs.  X1325402474

source_name: Ovarian Cancer Sample X1325402474


title: Ov_Tumor_Reference_Mix vs.  X1325402490

source_name: Ovarian Cancer Sample X1325402490


title: Ov_Tumor_Reference_Mix vs.  X1325402511

source_name: Ovarian Cancer Sample X1325402511


title: Ov_Tumor_Reference_Mix vs.  X1325402498

source_name: Ovarian Cancer Sample X1325402498


title: Ov_Tumor_Reference_Mix vs.  X1325402481

source_name: Ovarian Cancer Sample X1325402481


title: Ov_Tumor_Reference_Mix vs.  X1325402509

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1325402509


title: Ov_Tumor_Reference_Mix vs.  X1325402472

source_name: Ovarian Cancer Sample X1325402472


title: Ov_Tumor_Reference_Mix vs.  X1325402463

source_name: Ovarian Cancer Sample X1325402463


title: Ov_Tumor_Reference_Mix vs.  X1325402466

source_name: Ovarian Cancer Sample X1325402466


title: Ov_Tumor_Reference_Mix vs.  X1133903696

source_name: Ovarian Cancer Sample X1133903696


title: Ov_Tumor_Reference_Mix vs.  X1325402456

source_name: Ovarian Cancer Sample X1325402456


title: Ov_Tumor_Reference_Mix vs.  X1133903619

source_name: Ovarian Cancer Sample X1133903619


title: Ov_Tumor_Reference_Mix vs.  X1325402484

source_name: Ovarian Cancer Sample X1325402484


title: Ov_Tumor_Reference_Mix vs.  X1133903691

source_name: Ovarian Cancer Sample X1133903691


title: Ov_Tumor_Reference_Mix vs.  X1133903664

source_name: Ovarian Cancer Sample X1133903664


title: Ov_Tumor_Reference_Mix vs.  X1133903659

source_name: Ovarian Cancer Sample X1133903659


title: Ov_Tumor_Reference_Mix vs.  X1133903655

source_name: Ovarian Cancer Sample X1133903655


title: Ov_Tumor_Reference_Mix vs.  X1325402486

source_name: Ovarian Cancer Sample X1325402486


title: Ov_Tumor_Reference_Mix vs.  X1133903720

source_name: Ovarian Cancer Sample X1133903720


title: Ov_Tumor_Reference_Mix vs.  X1133903599

source_name: Ovarian Cancer Sample X1133903599


title: Ov_Tumor_Reference_Mix vs.  X1133903596

source_name: Ovarian Cancer Sample X1133903596


title: Ov_Tumor_Reference_Mix vs.  X1133903677

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903677


title: Ov_Tumor_Reference_Mix vs.  X1133903533

source_name: Ovarian Cancer Sample X1133903533


title: Ov_Tumor_Reference_Mix vs.  X1133902500

source_name: Ovarian Cancer Sample X1133902500


title: Ov_Tumor_Reference_Mix vs.  X1133903640

source_name: Ovarian Cancer Sample X1133903640


title: Ov_Tumor_Reference_Mix vs.  X1133902471

source_name: Ovarian Cancer Sample X1133902471


title: Ov_Tumor_Reference_Mix vs.  X1133903272.re.

source_name: Ovarian Cancer Sample X1133903272.re.


title: Ov_Tumor_Reference_Mix vs.  X1133903583

source_name: Ovarian Cancer Sample X1133903583


title: Ov_Tumor_Reference_Mix vs.  X1133902483

source_name: Ovarian Cancer Sample X1133902483


title: Ov_Tumor_Reference_Mix vs.  X1133903512

source_name: Ovarian Cancer Sample X1133903512


title: Ov_Tumor_Reference_Mix vs.  X1133902491

source_name: Ovarian Cancer Sample X1133902491


title: Ov_Tumor_Reference_Mix vs.  X1133903516

source_name: Ovarian Cancer Sample X1133903516


title: Ov_Tumor_Reference_Mix vs.  X1133903577

source_name: Ovarian Cancer Sample X1133903577


title: Ov_Tumor_Reference_Mix vs.  X1133903573

source_name: Ovarian Cancer Sample X1133903573


title: Ov_Tumor_Reference_Mix vs.  X1133903539

source_name: Ovarian Cancer Sample X1133903539


title: Ov_Tumor_Reference_Mix vs.  X1133903543

source_name: Ovarian Cancer Sample X1133903543


title: Ov_Tumor_Reference_Mix vs.  X1133902444

source_name: Ovarian Cancer Sample X1133902444


title: Ov_Tumor_Reference_Mix vs.  X1133903528

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903528


title: Ov_Tumor_Reference_Mix vs.  X1133903704

source_name: Ovarian Cancer Sample X1133903704


title: Ov_Tumor_Reference_Mix vs.  X1133903567

source_name: Ovarian Cancer Sample X1133903567


title: Ov_Tumor_Reference_Mix vs.  X1235201357

source_name: Ovarian Cancer Sample X1235201357


title: Ov_Tumor_Reference_Mix vs.  X1133902459

source_name: Ovarian Cancer Sample X1133902459


title: Ov_Tumor_Reference_Mix vs.  X1133903503

source_name: Ovarian Cancer Sample X1133903503


title: Ov_Tumor_Reference_Mix vs.  X1133902487

source_name: Ovarian Cancer Sample X1133902487


title: Ov_Tumor_Reference_Mix vs.  X1133902439

source_name: Ovarian Cancer Sample X1133902439


title: Ov_Tumor_Reference_Mix vs.  X1133903688

source_name: Ovarian Cancer Sample X1133903688


title: Ov_Tumor_Reference_Mix vs.  X1133903724

source_name: Ovarian Cancer Sample X1133903724


title: Ov_Tumor_Reference_Mix vs.  X1235201307

source_name: Ovarian Cancer Sample X1235201307


title: Ov_Tumor_Reference_Mix vs.  X1235201352

source_name: Ovarian Cancer Sample X1235201352


title: Ov_Tumor_Reference_Mix vs.  X1235201382

source_name: Ovarian Cancer Sample X1235201382


title: Ov_Tumor_Reference_Mix vs.  X1235201347

source_name: Ovarian Cancer Sample X1235201347


title: Ov_Tumor_Reference_Mix vs.  X1235201332

source_name: Ovarian Cancer Sample X1235201332


title: Ov_Tumor_Reference_Mix vs.  X1235201297

source_name: Ovarian Cancer Sample X1235201297


title: Ov_Tumor_Reference_Mix vs.  X1235201387

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1235201387


title: Ov_Tumor_Reference_Mix vs.  X1235201367

source_name: Ovarian Cancer Sample X1235201367


title: Ov_Tumor_Reference_Mix vs.  X1133903684

source_name: Ovarian Cancer Sample X1133903684


title: Ov_Tumor_Reference_Mix vs.  X1235201337

source_name: Ovarian Cancer Sample X1235201337


title: Ov_Tumor_Reference_Mix vs.  X1235201292

source_name: Ovarian Cancer Sample X1235201292


title: Ov_Tumor_Reference_Mix vs.  X1133903588

source_name: Ovarian Cancer Sample X1133903588


title: Ov_Tumor_Reference_Mix vs.  X1235201317

source_name: Ovarian Cancer Sample X1235201317


title: Ov_Tumor_Reference_Mix vs.  X1133903536

source_name: Ovarian Cancer Sample X1133903536


title: Ov_Tumor_Reference_Mix vs.  X1133903628

source_name: Ovarian Cancer Sample X1133903628


title: Ov_Tumor_Reference_Mix vs.  X1235201372

source_name: Ovarian Cancer Sample X1235201372


title: Ov_Tumor_Reference_Mix vs.  X1235201327

source_name: Ovarian Cancer Sample X1235201327


title: Ov_Tumor_Reference_Mix vs.  X1133902436

source_name: Ovarian Cancer Sample X1133902436


title: Ov_Tumor_Reference_Mix vs.  X1133903647

source_name: Ovarian Cancer Sample X1133903647


title: Ov_Tumor_Reference_Mix vs.  X1133903643

source_name: Ovarian Cancer Sample X1133903643


title: Ov_Tumor_Reference_Mix vs.  X1133903548

source_name: Ovarian Cancer Sample X1133903548


title: Ov_Tumor_Reference_Mix vs.  X1133903632

source_name: Ovarian Cancer Sample X1133903632


title: Ov_Tumor_Reference_Mix vs.  X1133903711

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903711


title: Ov_Tumor_Reference_Mix vs.  X1133903591

source_name: Ovarian Cancer Sample X1133903591


title: Ov_Tumor_Reference_Mix vs.  X1133903614

source_name: Ovarian Cancer Sample X1133903614


title: Ov_Tumor_Reference_Mix vs.  X1133902475

source_name: Ovarian Cancer Sample X1133902475


title: Ov_Tumor_Reference_Mix vs.  X1235201312

source_name: Ovarian Cancer Sample X1235201312


title: Ov_Tumor_Reference_Mix vs.  X1133903332

source_name: Ovarian Cancer Sample X1133903332


title: Ov_Tumor_Reference_Mix vs.  X1133903492

source_name: Ovarian Cancer Sample X1133903492


title: Ov_Tumor_Reference_Mix vs.  X1133903219

source_name: Ovarian Cancer Sample X1133903219


title: Ov_Tumor_Reference_Mix vs.  X1133902411

source_name: Ovarian Cancer Sample X1133902411


title: Ov_Tumor_Reference_Mix vs.  X1133903151

source_name: Ovarian Cancer Sample X1133903151


title: Ov_Tumor_Reference_Mix vs.  X1133903411

source_name: Ovarian Cancer Sample X1133903411


title: Ov_Tumor_Reference_Mix vs.  X1133903472

source_name: Ovarian Cancer Sample X1133903472


title: Ov_Tumor_Reference_Mix vs.  X1133903159

source_name: Ovarian Cancer Sample X1133903159


title: Ov_Tumor_Reference_Mix vs.  X1133903429

source_name: Ovarian Cancer Sample X1133903429


title: Ov_Tumor_Reference_Mix vs.  X1133903259

source_name: Ovarian Cancer Sample X1133903259


title: Ov_Tumor_Reference_Mix vs.  X1133903380

source_name: Ovarian Cancer Sample X1133903380


title: Ov_Tumor_Reference_Mix vs.  X1133903091

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903091


title: Ov_Tumor_Reference_Mix vs.  X1133903195

source_name: Ovarian Cancer Sample X1133903195


title: Ov_Tumor_Reference_Mix vs.  X1133902423

source_name: Ovarian Cancer Sample X1133902423


title: Ov_Tumor_Reference_Mix vs.  X1133903455

source_name: Ovarian Cancer Sample X1133903455


title: Ov_Tumor_Reference_Mix vs.  X1133903140

source_name: Ovarian Cancer Sample X1133903140


title: Ov_Tumor_Reference_Mix vs.  X1133903113

source_name: Ovarian Cancer Sample X1133903113


title: Ov_Tumor_Reference_Mix vs.  X1133903463

source_name: Ovarian Cancer Sample X1133903463


title: Ov_Tumor_Reference_Mix vs.  X1133903087

source_name: Ovarian Cancer Sample X1133903087


title: Ov_Tumor_Reference_Mix vs.  X1133903403

source_name: Ovarian Cancer Sample X1133903403


title: Ov_Tumor_Reference_Mix vs.  X1133903288

source_name: Ovarian Cancer Sample X1133903288


title: Ov_Tumor_Reference_Mix vs.  X1133903615

source_name: Ovarian Cancer Sample X1133903615


title: Ov_Tumor_Reference_Mix vs.  X1133903487

source_name: Ovarian Cancer Sample X1133903487


title: Ov_Tumor_Reference_Mix vs.  X1133903312

source_name: Ovarian Cancer Sample X1133903312


title: Ov_Tumor_Reference_Mix vs.  X1133903419

source_name: Ovarian Cancer Sample X1133903419


title: Ov_Tumor_Reference_Mix vs.  X1133903668

source_name: Ovarian Cancer Sample X1133903668


title: Ov_Tumor_Reference_Mix vs.  X1133903483

source_name: Ovarian Cancer Sample X1133903483


title: Ov_Tumor_Reference_Mix vs.  X1133903383

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903383


title: Ov_Tumor_Reference_Mix vs.  X1133903284

source_name: Ovarian Cancer Sample X1133903284


title: Ov_Tumor_Reference_Mix vs.  X1133903339

source_name: Ovarian Cancer Sample X1133903339


title: Ov_Tumor_Reference_Mix vs.  X1133903179

source_name: Ovarian Cancer Sample X1133903179


title: Ov_Tumor_Reference_Mix vs.  X1133903211

source_name: Ovarian Cancer Sample X1133903211


title: Ov_Tumor_Reference_Mix vs.  X1133903479

source_name: Ovarian Cancer Sample X1133903479


title: Ov_Tumor_Reference_Mix vs.  X1133903319

source_name: Ovarian Cancer Sample X1133903319


title: Ov_Tumor_Reference_Mix vs.  X1133903447

source_name: Ovarian Cancer Sample X1133903447


title: Ov_Tumor_Reference_Mix vs.  X1133903308

source_name: Ovarian Cancer Sample X1133903308


title: Ov_Tumor_Reference_Mix vs.  X1133903459

source_name: Ovarian Cancer Sample X1133903459


title: Ov_Tumor_Reference_Mix vs.  X1133903376

source_name: Ovarian Cancer Sample X1133903376


title: Ov_Tumor_Reference_Mix vs.  X1133903291

source_name: Ovarian Cancer Sample X1133903291


title: Ov_Tumor_Reference_Mix vs.  X1133903183

source_name: Ovarian Cancer Sample X1133903183


title: Ov_Tumor_Reference_Mix vs.  X1133903416

source_name: Ovarian Cancer Sample X1133903416


title: Ov_Tumor_Reference_Mix vs.  X1133903251

source_name: Ovarian Cancer Sample X1133903251


title: Ov_Tumor_Reference_Mix vs.  X1133903072

source_name: Ovarian Cancer Sample X1133903072


title: Ov_Tumor_Reference_Mix vs.  X1133903315

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903315


title: Ov_Tumor_Reference_Mix vs.  X1133903451

source_name: Ovarian Cancer Sample X1133903451


title: Ov_Tumor_Reference_Mix vs.  X1133903068

source_name: Ovarian Cancer Sample X1133903068


title: Ov_Tumor_Reference_Mix vs.  X1133903499

source_name: Ovarian Cancer Sample X1133903499


title: Ov_Tumor_Reference_Mix vs.  X1133903215

source_name: Ovarian Cancer Sample X1133903215


title: Ov_Tumor_Reference_Mix vs.  X1133903176

source_name: Ovarian Cancer Sample X1133903176


title: Ov_Tumor_Reference_Mix vs.  X1133903124

source_name: Ovarian Cancer Sample X1133903124


title: Ov_Tumor_Reference_Mix vs.  X1133903083

source_name: Ovarian Cancer Sample X1133903083


title: Ov_Tumor_Reference_Mix vs.  X1133903388

source_name: Ovarian Cancer Sample X1133903388


title: Ov_Tumor_Reference_Mix vs.  X1133903147

source_name: Ovarian Cancer Sample X1133903147


title: Ov_Tumor_Reference_Mix vs.  X1133903240

source_name: Ovarian Cancer Sample X1133903240


title: Ov_Tumor_Reference_Mix vs.  X1133903299

source_name: Ovarian Cancer Sample X1133903299


title: Ov_Tumor_Reference_Mix vs.  X1133903468

source_name: Ovarian Cancer Sample X1133903468


title: Ov_Tumor_Reference_Mix vs.  X1133903192

source_name: Ovarian Cancer Sample X1133903192


title: Ov_Tumor_Reference_Mix vs.  X1133903063

source_name: Ovarian Cancer Sample X1133903063


title: Ov_Tumor_Reference_Mix vs.  X1133903267

source_name: Ovarian Cancer Sample X1133903267


title: Ov_Tumor_Reference_Mix vs.  X1133903203

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903203


title: Ov_Tumor_Reference_Mix vs.  X1133903156

source_name: Ovarian Cancer Sample X1133903156


title: Ov_Tumor_Reference_Mix vs.  X1133903324

source_name: Ovarian Cancer Sample X1133903324


title: Ov_Tumor_Reference_Mix vs.  X1133903303

source_name: Ovarian Cancer Sample X1133903303


title: Ov_Tumor_Reference_Mix vs.  X1133903359

source_name: Ovarian Cancer Sample X1133903359


title: Ov_Tumor_Reference_Mix vs.  X1133903391

source_name: Ovarian Cancer Sample X1133903391


title: Ov_Tumor_Reference_Mix vs.  X1133903167

source_name: Ovarian Cancer Sample X1133903167


title: Ov_Tumor_Reference_Mix vs.  X1133903295

source_name: Ovarian Cancer Sample X1133903295


title: Ov_Tumor_Reference_Mix vs.  X1133903235

source_name: Ovarian Cancer Sample X1133903235


title: Ov_Tumor_Reference_Mix vs.  X1133903363

source_name: Ovarian Cancer Sample X1133903363


title: Ov_Tumor_Reference_Mix vs.  X1133903079

source_name: Ovarian Cancer Sample X1133903079


title: Ov_Tumor_Reference_Mix vs.  X1133903327

source_name: Ovarian Cancer Sample X1133903327


title: Ov_Tumor_Reference_Mix vs.  X1133903004

source_name: Ovarian Cancer Sample X1133903004


title: Ov_Tumor_Reference_Mix vs.  X1133902688

source_name: Ovarian Cancer Sample X1133902688


title: Ov_Tumor_Reference_Mix vs.  X1133903344

source_name: Ovarian Cancer Sample X1133903344


title: Ov_Tumor_Reference_Mix vs.  X1133903495

source_name: Ovarian Cancer Sample X1133903495


title: Ov_Tumor_Reference_Mix vs.  X1133903056

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133903056


title: Ov_Tumor_Reference_Mix vs.  X1133902824

source_name: Ovarian Cancer Sample X1133902824


title: Ov_Tumor_Reference_Mix vs.  X1133902660

source_name: Ovarian Cancer Sample X1133902660


title: Ov_Tumor_Reference_Mix vs.  X1133903200

source_name: Ovarian Cancer Sample X1133903200


title: Ov_Tumor_Reference_Mix vs.  X1133903245

source_name: Ovarian Cancer Sample X1133903245


title: Ov_Tumor_Reference_Mix vs.  X1133903044

source_name: Ovarian Cancer Sample X1133903044


title: Ov_Tumor_Reference_Mix vs.  X1133902655

source_name: Ovarian Cancer Sample X1133902655


title: Ov_Tumor_Reference_Mix vs.  X1133902939

source_name: Ovarian Cancer Sample X1133902939


title: Ov_Tumor_Reference_Mix vs.  X1133902800

source_name: Ovarian Cancer Sample X1133902800


title: Ov_Tumor_Reference_Mix vs.  X1133902776

source_name: Ovarian Cancer Sample X1133902776


title: Ov_Tumor_Reference_Mix vs.  X1133902896

source_name: Ovarian Cancer Sample X1133902896


title: Ov_Tumor_Reference_Mix vs.  X1133902503

source_name: Ovarian Cancer Sample X1133902503


title: Ov_Tumor_Reference_Mix vs.  X1133902740

source_name: Ovarian Cancer Sample X1133902740


title: Ov_Tumor_Reference_Mix vs.  X1133902760

source_name: Ovarian Cancer Sample X1133902760


title: Ov_Tumor_Reference_Mix vs.  X1133902764

source_name: Ovarian Cancer Sample X1133902764


title: Ov_Tumor_Reference_Mix vs.  X1133902992

source_name: Ovarian Cancer Sample X1133902992


title: Ov_Tumor_Reference_Mix vs.  X1133902972

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133902972


title: Ov_Tumor_Reference_Mix vs.  X1133902819

source_name: Ovarian Cancer Sample X1133902819


title: Ov_Tumor_Reference_Mix vs.  X1133902980

source_name: Ovarian Cancer Sample X1133902980


title: Ov_Tumor_Reference_Mix vs.  X1133903355

source_name: Ovarian Cancer Sample X1133903355


title: Ov_Tumor_Reference_Mix vs.  X1133902892

source_name: Ovarian Cancer Sample X1133902892


title: Ov_Tumor_Reference_Mix vs.  X1133902720

source_name: Ovarian Cancer Sample X1133902720


title: Ov_Tumor_Reference_Mix vs.  X1133902852

source_name: Ovarian Cancer Sample X1133902852


title: Ov_Tumor_Reference_Mix vs.  X1133902727

source_name: Ovarian Cancer Sample X1133902727


title: Ov_Tumor_Reference_Mix vs.  X1133902704

source_name: Ovarian Cancer Sample X1133902704


title: Ov_Tumor_Reference_Mix vs.  X1133902864

source_name: Ovarian Cancer Sample X1133902864


title: Ov_Tumor_Reference_Mix vs.  X1133902792

source_name: Ovarian Cancer Sample X1133902792


title: Ov_Tumor_Reference_Mix vs.  X1133902723

source_name: Ovarian Cancer Sample X1133902723


title: Ov_Tumor_Reference_Mix vs.  X1133903027

source_name: Ovarian Cancer Sample X1133903027


title: Ov_Tumor_Reference_Mix vs.  X1133902623

source_name: Ovarian Cancer Sample X1133902623


title: Ov_Tumor_Reference_Mix vs.  X1133902840

source_name: Ovarian Cancer Sample X1133902840


title: Ov_Tumor_Reference_Mix vs.  X1133902967

source_name: Ovarian Cancer Sample X1133902967


title: Ov_Tumor_Reference_Mix vs.  X1133902615

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133902615


title: Ov_Tumor_Reference_Mix vs.  X1133902779

source_name: Ovarian Cancer Sample X1133902779


title: Ov_Tumor_Reference_Mix vs.  X1133903031

source_name: Ovarian Cancer Sample X1133903031


title: Ov_Tumor_Reference_Mix vs.  X1133902831

source_name: Ovarian Cancer Sample X1133902831


title: Ov_Tumor_Reference_Mix vs.  X1133902903

source_name: Ovarian Cancer Sample X1133902903


title: Ov_Tumor_Reference_Mix vs.  X1133902827

source_name: Ovarian Cancer Sample X1133902827


title: Ov_Tumor_Reference_Mix vs.  X1133902752

source_name: Ovarian Cancer Sample X1133902752


title: Ov_Tumor_Reference_Mix vs.  X1133903015

source_name: Ovarian Cancer Sample X1133903015


title: Ov_Tumor_Reference_Mix vs.  X1133902563

source_name: Ovarian Cancer Sample X1133902563


title: Ov_Tumor_Reference_Mix vs.  X1133902963

source_name: Ovarian Cancer Sample X1133902963


title: Ov_Tumor_Reference_Mix vs.  X1133902611

source_name: Ovarian Cancer Sample X1133902611


title: Ov_Tumor_Reference_Mix vs.  X1133902808

source_name: Ovarian Cancer Sample X1133902808


title: Ov_Tumor_Reference_Mix vs.  X1133903007

source_name: Ovarian Cancer Sample X1133903007


title: Ov_Tumor_Reference_Mix vs.  X1133902567

source_name: Ovarian Cancer Sample X1133902567


title: Ov_Tumor_Reference_Mix vs.  X1133902999

source_name: Ovarian Cancer Sample X1133902999


title: Ov_Tumor_Reference_Mix vs.  X1133902907

source_name: Ovarian Cancer Sample X1133902907


title: Ov_Tumor_Reference_Mix vs.  X1133902635

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133902635


title: Ov_Tumor_Reference_Mix vs.  X1133902928

source_name: Ovarian Cancer Sample X1133902928


title: Ov_Tumor_Reference_Mix vs.  X1133902843

source_name: Ovarian Cancer Sample X1133902843


title: Ov_Tumor_Reference_Mix vs.  X1133902676

source_name: Ovarian Cancer Sample X1133902676


title: Ov_Tumor_Reference_Mix vs.  X1133902651

source_name: Ovarian Cancer Sample X1133902651


title: Ov_Tumor_Reference_Mix vs.  X1133902699

source_name: Ovarian Cancer Sample X1133902699


title: Ov_Tumor_Reference_Mix vs.  X1133902707

source_name: Ovarian Cancer Sample X1133902707


title: Ov_Tumor_Reference_Mix vs.  X1133902647

source_name: Ovarian Cancer Sample X1133902647


title: Ov_Tumor_Reference_Mix vs.  X1133902900

source_name: Ovarian Cancer Sample X1133902900


title: Ov_Tumor_Reference_Mix vs.  X1133902671

source_name: Ovarian Cancer Sample X1133902671


title: Ov_Tumor_Reference_Mix vs.  X1133903011

source_name: Ovarian Cancer Sample X1133903011


title: Ov_Tumor_Reference_Mix vs.  X1133902595

source_name: Ovarian Cancer Sample X1133902595


title: Ov_Tumor_Reference_Mix vs.  X1133902711

source_name: Ovarian Cancer Sample X1133902711


title: Ov_Tumor_Reference_Mix vs.  X1133902575

source_name: Ovarian Cancer Sample X1133902575


title: Ov_Tumor_Reference_Mix vs.  X1133902683

source_name: Ovarian Cancer Sample X1133902683


title: Ov_Tumor_Reference_Mix vs.  X1133902773

source_name: Ovarian Cancer Sample X1133902773


title: Ov_Tumor_Reference_Mix vs.  X1133902587

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X1133902587


title: Ov_Tumor_Reference_Mix vs.  X1133902735

source_name: Ovarian Cancer Sample X1133902735


title: Ov_Tumor_Reference_Mix vs.  X1133902731

source_name: Ovarian Cancer Sample X1133902731


title: Ov_Tumor_Reference_Mix vs.  X1133902836

source_name: Ovarian Cancer Sample X1133902836


title: Ov_Tumor_Reference_Mix vs.  X1133902976

source_name: Ovarian Cancer Sample X1133902976


title: Ov_Tumor_Reference_Mix vs.  X1133902551

source_name: Ovarian Cancer Sample X1133902551


title: Ov_Tumor_Reference_Mix vs.  X1133902804

source_name: Ovarian Cancer Sample X1133902804


title: Ov_Tumor_Reference_Mix vs.  X1133902987

source_name: Ovarian Cancer Sample X1133902987


title: Ov_Tumor_Reference_Mix vs.  X1133902696

source_name: Ovarian Cancer Sample X1133902696


title: Ov_Tumor_Reference_Mix vs.  X5384

source_name: Ovarian Cancer Sample X5384


title: Ov_Tumor_Reference_Mix vs.  X1133902556

source_name: Ovarian Cancer Sample X1133902556


title: Ov_Tumor_Reference_Mix vs.  X1133902507

source_name: Ovarian Cancer Sample X1133902507


title: Ov_Tumor_Reference_Mix vs.  X1133902744

source_name: Ovarian Cancer Sample X1133902744


title: Ov_Tumor_Reference_Mix vs.  X5385

source_name: Ovarian Cancer Sample X5385


title: Ov_Tumor_Reference_Mix vs.  X1133902693

source_name: Ovarian Cancer Sample X1133902693


title: Ov_Tumor_Reference_Mix vs.  X5382

source_name: Ovarian Cancer Sample X5382


title: Ov_Tumor_Reference_Mix vs.  X5383

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X5383


title: Ov_Tumor_Reference_Mix vs.  X5376

source_name: Ovarian Cancer Sample X5376


title: Ov_Tumor_Reference_Mix vs.  X1133902531

source_name: Ovarian Cancer Sample X1133902531


title: Ov_Tumor_Reference_Mix vs.  X5381

source_name: Ovarian Cancer Sample X5381


title: Ov_Tumor_Reference_Mix vs.  X1133902607

source_name: Ovarian Cancer Sample X1133902607


title: Ov_Tumor_Reference_Mix vs.  X5374

source_name: Ovarian Cancer Sample X5374


title: Ov_Tumor_Reference_Mix vs.  X1133902579

source_name: Ovarian Cancer Sample X1133902579


title: Ov_Tumor_Reference_Mix vs.  X4302

source_name: Ovarian Cancer Sample X4302


title: Ov_Tumor_Reference_Mix vs.  X4289

source_name: Ovarian Cancer Sample X4289


title: Ov_Tumor_Reference_Mix vs.  X4459

source_name: Ovarian Cancer Sample X4459


title: Ov_Tumor_Reference_Mix vs.  X5386

source_name: Ovarian Cancer Sample X5386


title: Ov_Tumor_Reference_Mix vs.  X5375

source_name: Ovarian Cancer Sample X5375


title: Ov_Tumor_Reference_Mix vs.  X4301

source_name: Ovarian Cancer Sample X4301


title: Ov_Tumor_Reference_Mix vs.  X4300

source_name: Ovarian Cancer Sample X4300


title: Ov_Tumor_Reference_Mix vs.  X4292

source_name: Ovarian Cancer Sample X4292


title: Ov_Tumor_Reference_Mix vs.  X4294

source_name: Ovarian Cancer Sample X4294


title: Ov_Tumor_Reference_Mix vs.  X4299

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4299


title: Ov_Tumor_Reference_Mix vs.  X4467

source_name: Ovarian Cancer Sample X4467


title: Ov_Tumor_Reference_Mix vs.  X4293

source_name: Ovarian Cancer Sample X4293


title: Ov_Tumor_Reference_Mix vs.  X5387

source_name: Ovarian Cancer Sample X5387


title: Ov_Tumor_Reference_Mix vs.  X4288

source_name: Ovarian Cancer Sample X4288


title: Ov_Tumor_Reference_Mix vs.  X4287

source_name: Ovarian Cancer Sample X4287


title: Ov_Tumor_Reference_Mix vs.  X4291

source_name: Ovarian Cancer Sample X4291


title: Ov_Tumor_Reference_Mix vs.  X5373

source_name: Ovarian Cancer Sample X5373


title: Ov_Tumor_Reference_Mix vs.  X4279

source_name: Ovarian Cancer Sample X4279


title: Ov_Tumor_Reference_Mix vs.  X4281

source_name: Ovarian Cancer Sample X4281


title: Ov_Tumor_Reference_Mix vs.  X4278

source_name: Ovarian Cancer Sample X4278


title: Ov_Tumor_Reference_Mix vs.  X4286

source_name: Ovarian Cancer Sample X4286


title: Ov_Tumor_Reference_Mix vs.  X4273

source_name: Ovarian Cancer Sample X4273


title: Ov_Tumor_Reference_Mix vs.  X4283

source_name: Ovarian Cancer Sample X4283


title: Ov_Tumor_Reference_Mix vs.  X4284

source_name: Ovarian Cancer Sample X4284


title: Ov_Tumor_Reference_Mix vs.  X4280

source_name: Ovarian Cancer Sample X4280


title: Ov_Tumor_Reference_Mix vs.  X4277

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4277


title: Ov_Tumor_Reference_Mix vs.  X4282

source_name: Ovarian Cancer Sample X4282


title: Ov_Tumor_Reference_Mix vs.  X4285

source_name: Ovarian Cancer Sample X4285


title: Ov_Tumor_Reference_Mix vs.  X4275

source_name: Ovarian Cancer Sample X4275


title: Ov_Tumor_Reference_Mix vs.  X4271

source_name: Ovarian Cancer Sample X4271


title: Ov_Tumor_Reference_Mix vs.  X4272

source_name: Ovarian Cancer Sample X4272


title: Ov_Tumor_Reference_Mix vs.  X4290

source_name: Ovarian Cancer Sample X4290


title: Ov_Tumor_Reference_Mix vs.  X4267

source_name: Ovarian Cancer Sample X4267


title: Ov_Tumor_Reference_Mix vs.  X4270

source_name: Ovarian Cancer Sample X4270


title: Ov_Tumor_Reference_Mix vs.  X4262

source_name: Ovarian Cancer Sample X4262


title: Ov_Tumor_Reference_Mix vs.  X4265

source_name: Ovarian Cancer Sample X4265


title: Ov_Tumor_Reference_Mix vs.  X4274

source_name: Ovarian Cancer Sample X4274


title: Ov_Tumor_Reference_Mix vs.  X4266

source_name: Ovarian Cancer Sample X4266


title: Ov_Tumor_Reference_Mix vs.  X4260

source_name: Ovarian Cancer Sample X4260


title: Ov_Tumor_Reference_Mix vs.  X4269

source_name: Ovarian Cancer Sample X4269


title: Ov_Tumor_Reference_Mix vs.  X4276

source_name: Ovarian Cancer Sample X4276


title: Ov_Tumor_Reference_Mix vs.  X4261

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4261


title: Ov_Tumor_Reference_Mix vs.  X4259

source_name: Ovarian Cancer Sample X4259


title: Ov_Tumor_Reference_Mix vs.  X4263

source_name: Ovarian Cancer Sample X4263


title: Ov_Tumor_Reference_Mix vs.  X4258

source_name: Ovarian Cancer Sample X4258


title: Ov_Tumor_Reference_Mix vs.  X4257

source_name: Ovarian Cancer Sample X4257


title: Ov_Tumor_Reference_Mix vs.  X4255

source_name: Ovarian Cancer Sample X4255


title: Ov_Tumor_Reference_Mix vs.  X4251

source_name: Ovarian Cancer Sample X4251


title: Ov_Tumor_Reference_Mix vs.  X4245

source_name: Ovarian Cancer Sample X4245


title: Ov_Tumor_Reference_Mix vs.  X4249

source_name: Ovarian Cancer Sample X4249


title: Ov_Tumor_Reference_Mix vs.  X4256

source_name: Ovarian Cancer Sample X4256


title: Ov_Tumor_Reference_Mix vs.  X4242

source_name: Ovarian Cancer Sample X4242


title: Ov_Tumor_Reference_Mix vs.  X4240

source_name: Ovarian Cancer Sample X4240


title: Ov_Tumor_Reference_Mix vs.  X4250

source_name: Ovarian Cancer Sample X4250


title: Ov_Tumor_Reference_Mix vs.  X4243

source_name: Ovarian Cancer Sample X4243


title: Ov_Tumor_Reference_Mix vs.  X4254

source_name: Ovarian Cancer Sample X4254


title: Ov_Tumor_Reference_Mix vs.  X4241

source_name: Ovarian Cancer Sample X4241


title: Ov_Tumor_Reference_Mix vs.  X4244

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4244


title: Ov_Tumor_Reference_Mix vs.  X4253

source_name: Ovarian Cancer Sample X4253


title: Ov_Tumor_Reference_Mix vs.  X4264

source_name: Ovarian Cancer Sample X4264


title: Ov_Tumor_Reference_Mix vs.  X4238

source_name: Ovarian Cancer Sample X4238


title: Ov_Tumor_Reference_Mix vs.  X4239

source_name: Ovarian Cancer Sample X4239


title: Ov_Tumor_Reference_Mix vs.  X4235

source_name: Ovarian Cancer Sample X4235


title: Ov_Tumor_Reference_Mix vs.  X4236

source_name: Ovarian Cancer Sample X4236


title: Ov_Tumor_Reference_Mix vs.  X4227

source_name: Ovarian Cancer Sample X4227


title: Ov_Tumor_Reference_Mix vs.  X4230

source_name: Ovarian Cancer Sample X4230


title: Ov_Tumor_Reference_Mix vs.  X4228

source_name: Ovarian Cancer Sample X4228


title: Ov_Tumor_Reference_Mix vs.  X4234

source_name: Ovarian Cancer Sample X4234


title: Ov_Tumor_Reference_Mix vs.  X4237

source_name: Ovarian Cancer Sample X4237


title: Ov_Tumor_Reference_Mix vs.  X4232

source_name: Ovarian Cancer Sample X4232


title: Ov_Tumor_Reference_Mix vs.  X4221

source_name: Ovarian Cancer Sample X4221


title: Ov_Tumor_Reference_Mix vs.  X4226

source_name: Ovarian Cancer Sample X4226


title: Ov_Tumor_Reference_Mix vs.  X4220

source_name: Ovarian Cancer Sample X4220


title: Ov_Tumor_Reference_Mix vs.  X4233

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4233


title: Ov_Tumor_Reference_Mix vs.  X4229

source_name: Ovarian Cancer Sample X4229


title: Ov_Tumor_Reference_Mix vs.  X4225

source_name: Ovarian Cancer Sample X4225


title: Ov_Tumor_Reference_Mix vs.  X4219

source_name: Ovarian Cancer Sample X4219


title: Ov_Tumor_Reference_Mix vs.  X4217

source_name: Ovarian Cancer Sample X4217


title: Ov_Tumor_Reference_Mix vs.  X4216

source_name: Ovarian Cancer Sample X4216


title: Ov_Tumor_Reference_Mix vs.  X4209

source_name: Ovarian Cancer Sample X4209


title: Ov_Tumor_Reference_Mix vs.  X4212

source_name: Ovarian Cancer Sample X4212


title: Ov_Tumor_Reference_Mix vs.  X4211

source_name: Ovarian Cancer Sample X4211


title: Ov_Tumor_Reference_Mix vs.  X4206

source_name: Ovarian Cancer Sample X4206


title: Ov_Tumor_Reference_Mix vs.  X4205

source_name: Ovarian Cancer Sample X4205


title: Ov_Tumor_Reference_Mix vs.  X4202

source_name: Ovarian Cancer Sample X4202


title: Ov_Tumor_Reference_Mix vs.  X4218

source_name: Ovarian Cancer Sample X4218


title: Ov_Tumor_Reference_Mix vs.  X4204

source_name: Ovarian Cancer Sample X4204


title: Ov_Tumor_Reference_Mix vs.  X4215

source_name: Ovarian Cancer Sample X4215


title: Ov_Tumor_Reference_Mix vs.  X4214

source_name: Ovarian Cancer Sample X4214


title: Ov_Tumor_Reference_Mix vs.  X4207

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4207


title: Ov_Tumor_Reference_Mix vs.  X4213

source_name: Ovarian Cancer Sample X4213


title: Ov_Tumor_Reference_Mix vs.  X4208

source_name: Ovarian Cancer Sample X4208


title: Ov_Tumor_Reference_Mix vs.  X4201

source_name: Ovarian Cancer Sample X4201


title: Ov_Tumor_Reference_Mix vs.  X4195

source_name: Ovarian Cancer Sample X4195


title: Ov_Tumor_Reference_Mix vs.  X4194

source_name: Ovarian Cancer Sample X4194


title: Ov_Tumor_Reference_Mix vs.  X4193

source_name: Ovarian Cancer Sample X4193


title: Ov_Tumor_Reference_Mix vs.  X4190

source_name: Ovarian Cancer Sample X4190


title: Ov_Tumor_Reference_Mix vs.  X4192

source_name: Ovarian Cancer Sample X4192


title: Ov_Tumor_Reference_Mix vs.  X4199

source_name: Ovarian Cancer Sample X4199


title: Ov_Tumor_Reference_Mix vs.  X4198

source_name: Ovarian Cancer Sample X4198


title: Ov_Tumor_Reference_Mix vs.  X4203

source_name: Ovarian Cancer Sample X4203


title: Ov_Tumor_Reference_Mix vs.  X4191

source_name: Ovarian Cancer Sample X4191


title: Ov_Tumor_Reference_Mix vs.  X4200

source_name: Ovarian Cancer Sample X4200


title: Ov_Tumor_Reference_Mix vs.  X4196

source_name: Ovarian Cancer Sample X4196


title: Ov_Tumor_Reference_Mix vs.  X4197

source_name: Ovarian Cancer Sample X4197


title: Ov_Tumor_Reference_Mix vs.  X4189

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4189


title: Ov_Tumor_Reference_Mix vs.  X4188

source_name: Ovarian Cancer Sample X4188


title: Ov_Tumor_Reference_Mix vs.  X4187

source_name: Ovarian Cancer Sample X4187


title: Ov_Tumor_Reference_Mix vs.  X4180

source_name: Ovarian Cancer Sample X4180


title: Ov_Tumor_Reference_Mix vs.  X4173

source_name: Ovarian Cancer Sample X4173


title: Ov_Tumor_Reference_Mix vs.  X4184

source_name: Ovarian Cancer Sample X4184


title: Ov_Tumor_Reference_Mix vs.  X4178

source_name: Ovarian Cancer Sample X4178


title: Ov_Tumor_Reference_Mix vs.  X4186

source_name: Ovarian Cancer Sample X4186


title: Ov_Tumor_Reference_Mix vs.  X4183

source_name: Ovarian Cancer Sample X4183


title: Ov_Tumor_Reference_Mix vs.  X4175

source_name: Ovarian Cancer Sample X4175


title: Ov_Tumor_Reference_Mix vs.  X4181

source_name: Ovarian Cancer Sample X4181


title: Ov_Tumor_Reference_Mix vs.  X4179

source_name: Ovarian Cancer Sample X4179


title: Ov_Tumor_Reference_Mix vs.  X4185

source_name: Ovarian Cancer Sample X4185


title: Ov_Tumor_Reference_Mix vs.  X4169

source_name: Ovarian Cancer Sample X4169


title: Ov_Tumor_Reference_Mix vs.  X4174

source_name: Ovarian Cancer Sample X4174


title: Ov_Tumor_Reference_Mix vs.  X4176

source_name: Ovarian Cancer Sample X4176


title: Ov_Tumor_Reference_Mix vs.  X4177

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4177


title: Ov_Tumor_Reference_Mix vs.  X4168

source_name: Ovarian Cancer Sample X4168


title: Ov_Tumor_Reference_Mix vs.  X4171

source_name: Ovarian Cancer Sample X4171


title: Ov_Tumor_Reference_Mix vs.  X4170

source_name: Ovarian Cancer Sample X4170


title: Ov_Tumor_Reference_Mix vs.  X4166

source_name: Ovarian Cancer Sample X4166


title: Ov_Tumor_Reference_Mix vs.  X4162

source_name: Ovarian Cancer Sample X4162


title: Ov_Tumor_Reference_Mix vs.  X4165

source_name: Ovarian Cancer Sample X4165


title: Ov_Tumor_Reference_Mix vs.  X4160

source_name: Ovarian Cancer Sample X4160


title: Ov_Tumor_Reference_Mix vs.  X4172

source_name: Ovarian Cancer Sample X4172


title: Ov_Tumor_Reference_Mix vs.  X4163

source_name: Ovarian Cancer Sample X4163


title: Ov_Tumor_Reference_Mix vs.  X4161

source_name: Ovarian Cancer Sample X4161


title: Ov_Tumor_Reference_Mix vs.  X4158

source_name: Ovarian Cancer Sample X4158


title: Ov_Tumor_Reference_Mix vs.  X4167

source_name: Ovarian Cancer Sample X4167


title: Ov_Tumor_Reference_Mix vs.  X4159

source_name: Ovarian Cancer Sample X4159


title: Ov_Tumor_Reference_Mix vs.  X4164

source_name: Ovarian Cancer Sample X4164


title: Ov_Tumor_Reference_Mix vs.  X4157

source_name: Ovarian Cancer Sample X4157


title: Ov_Tumor_Reference_Mix vs.  X4156

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4156


title: Ov_Tumor_Reference_Mix vs.  X4154

source_name: Ovarian Cancer Sample X4154


title: Ov_Tumor_Reference_Mix vs.  X4155

source_name: Ovarian Cancer Sample X4155


title: Ov_Tumor_Reference_Mix vs.  X4153

source_name: Ovarian Cancer Sample X4153


title: Ov_Tumor_Reference_Mix vs.  X4145

source_name: Ovarian Cancer Sample X4145


title: Ov_Tumor_Reference_Mix vs.  X4150

source_name: Ovarian Cancer Sample X4150


title: Ov_Tumor_Reference_Mix vs.  X4151

source_name: Ovarian Cancer Sample X4151


title: Ov_Tumor_Reference_Mix vs.  X4147

source_name: Ovarian Cancer Sample X4147


title: Ov_Tumor_Reference_Mix vs.  X4140

source_name: Ovarian Cancer Sample X4140


title: Ov_Tumor_Reference_Mix vs.  X4139

source_name: Ovarian Cancer Sample X4139


title: Ov_Tumor_Reference_Mix vs.  X4142

source_name: Ovarian Cancer Sample X4142


title: Ov_Tumor_Reference_Mix vs.  X4149

source_name: Ovarian Cancer Sample X4149


title: Ov_Tumor_Reference_Mix vs.  X4143

source_name: Ovarian Cancer Sample X4143


title: Ov_Tumor_Reference_Mix vs.  X4144

source_name: Ovarian Cancer Sample X4144


title: Ov_Tumor_Reference_Mix vs.  X4137

source_name: Ovarian Cancer Sample X4137


title: Ov_Tumor_Reference_Mix vs.  X4136

source_name: Ovarian Cancer Sample X4136


title: Ov_Tumor_Reference_Mix vs.  X4138

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4138


title: Ov_Tumor_Reference_Mix vs.  X4135

source_name: Ovarian Cancer Sample X4135


title: Ov_Tumor_Reference_Mix vs.  X4146

source_name: Ovarian Cancer Sample X4146


title: Ov_Tumor_Reference_Mix vs.  X4132

source_name: Ovarian Cancer Sample X4132


title: Ov_Tumor_Reference_Mix vs.  X4131

source_name: Ovarian Cancer Sample X4131


title: Ov_Tumor_Reference_Mix vs.  X4141

source_name: Ovarian Cancer Sample X4141


title: Ov_Tumor_Reference_Mix vs.  X4134

source_name: Ovarian Cancer Sample X4134


title: Ov_Tumor_Reference_Mix vs.  X4128

source_name: Ovarian Cancer Sample X4128


title: Ov_Tumor_Reference_Mix vs.  X4129

source_name: Ovarian Cancer Sample X4129


title: Ov_Tumor_Reference_Mix vs.  X4127

source_name: Ovarian Cancer Sample X4127


title: Ov_Tumor_Reference_Mix vs.  X4152

source_name: Ovarian Cancer Sample X4152


title: Ov_Tumor_Reference_Mix vs.  X4126

source_name: Ovarian Cancer Sample X4126


title: Ov_Tumor_Reference_Mix vs.  X4125

source_name: Ovarian Cancer Sample X4125


title: Ov_Tumor_Reference_Mix vs.  X4133

source_name: Ovarian Cancer Sample X4133


title: Ov_Tumor_Reference_Mix vs.  X4210

source_name: Ovarian Cancer Sample X4210


title: Ov_Tumor_Reference_Mix vs.  X4124

source_name: Ovarian Cancer Sample X4124


title: Ov_Tumor_Reference_Mix vs.  X4123

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4123


title: Ov_Tumor_Reference_Mix vs.  X4117

source_name: Ovarian Cancer Sample X4117


title: Ov_Tumor_Reference_Mix vs.  X4122

source_name: Ovarian Cancer Sample X4122


title: Ov_Tumor_Reference_Mix vs.  X4120

source_name: Ovarian Cancer Sample X4120


title: Ov_Tumor_Reference_Mix vs.  X4121

source_name: Ovarian Cancer Sample X4121


title: Ov_Tumor_Reference_Mix vs.  X4114

source_name: Ovarian Cancer Sample X4114


title: Ov_Tumor_Reference_Mix vs.  X4110

source_name: Ovarian Cancer Sample X4110


title: Ov_Tumor_Reference_Mix vs.  X4115

source_name: Ovarian Cancer Sample X4115


title: Ov_Tumor_Reference_Mix vs.  X4119

source_name: Ovarian Cancer Sample X4119


title: Ov_Tumor_Reference_Mix vs.  X4113

source_name: Ovarian Cancer Sample X4113


title: Ov_Tumor_Reference_Mix vs.  X4099

source_name: Ovarian Cancer Sample X4099


title: Ov_Tumor_Reference_Mix vs.  X4118

source_name: Ovarian Cancer Sample X4118


title: Ov_Tumor_Reference_Mix vs.  X4104

source_name: Ovarian Cancer Sample X4104


title: Ov_Tumor_Reference_Mix vs.  X4116

source_name: Ovarian Cancer Sample X4116


title: Ov_Tumor_Reference_Mix vs.  X4112

source_name: Ovarian Cancer Sample X4112


title: Ov_Tumor_Reference_Mix vs.  X4101

source_name: Ovarian Cancer Sample X4101


title: Ov_Tumor_Reference_Mix vs.  X4106

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4106


title: Ov_Tumor_Reference_Mix vs.  X4109

source_name: Ovarian Cancer Sample X4109


title: Ov_Tumor_Reference_Mix vs.  X4098

source_name: Ovarian Cancer Sample X4098


title: Ov_Tumor_Reference_Mix vs.  X4107

source_name: Ovarian Cancer Sample X4107


title: Ov_Tumor_Reference_Mix vs.  X4100

source_name: Ovarian Cancer Sample X4100


title: Ov_Tumor_Reference_Mix vs.  X4102

source_name: Ovarian Cancer Sample X4102


title: Ov_Tumor_Reference_Mix vs.  X4103

source_name: Ovarian Cancer Sample X4103


title: Ov_Tumor_Reference_Mix vs.  X4111

source_name: Ovarian Cancer Sample X4111


title: Ov_Tumor_Reference_Mix vs.  X4108

source_name: Ovarian Cancer Sample X4108


title: Ov_Tumor_Reference_Mix vs.  X4097

source_name: Ovarian Cancer Sample X4097


title: Ov_Tumor_Reference_Mix vs.  X4095

source_name: Ovarian Cancer Sample X4095


title: Ov_Tumor_Reference_Mix vs.  X4105

source_name: Ovarian Cancer Sample X4105


title: Ov_Tumor_Reference_Mix vs.  X4096

source_name: Ovarian Cancer Sample X4096


title: Ov_Tumor_Reference_Mix vs.  X4094

source_name: Ovarian Cancer Sample X4094


title: Ov_Tumor_Reference_Mix vs.  X4091

source_name: Ovarian Cancer Sample X4091


title: Ov_Tumor_Reference_Mix vs.  X4081

source_name: Ovarian Cancer Sample X4081


title: Ov_Tumor_Reference_Mix vs.  X4093

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4093


title: Ov_Tumor_Reference_Mix vs.  X4086

source_name: Ovarian Cancer Sample X4086


title: Ov_Tumor_Reference_Mix vs.  X4087

source_name: Ovarian Cancer Sample X4087


title: Ov_Tumor_Reference_Mix vs.  X4088

source_name: Ovarian Cancer Sample X4088


title: Ov_Tumor_Reference_Mix vs.  X4090

source_name: Ovarian Cancer Sample X4090


title: Ov_Tumor_Reference_Mix vs.  X4085

source_name: Ovarian Cancer Sample X4085


title: Ov_Tumor_Reference_Mix vs.  X4064

source_name: Ovarian Cancer Sample X4064


title: Ov_Tumor_Reference_Mix vs.  X4089

source_name: Ovarian Cancer Sample X4089


title: Ov_Tumor_Reference_Mix vs.  X4069

source_name: Ovarian Cancer Sample X4069


title: Ov_Tumor_Reference_Mix vs.  X4072

source_name: Ovarian Cancer Sample X4072


title: Ov_Tumor_Reference_Mix vs.  X4073

source_name: Ovarian Cancer Sample X4073


title: Ov_Tumor_Reference_Mix vs.  X4074

source_name: Ovarian Cancer Sample X4074


title: Ov_Tumor_Reference_Mix vs.  X4080

source_name: Ovarian Cancer Sample X4080


title: Ov_Tumor_Reference_Mix vs.  X4092

source_name: Ovarian Cancer Sample X4092


title: Ov_Tumor_Reference_Mix vs.  X4084

source_name: Ovarian Cancer Sample X4084


title: Ov_Tumor_Reference_Mix vs.  X4067

source_name: Ovarian Cancer Sample X4067


title: Ov_Tumor_Reference_Mix vs.  X4077

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4077


title: Ov_Tumor_Reference_Mix vs.  X4063

source_name: Ovarian Cancer Sample X4063


title: Ov_Tumor_Reference_Mix vs.  X4082

source_name: Ovarian Cancer Sample X4082


title: Ov_Tumor_Reference_Mix vs.  X4083

source_name: Ovarian Cancer Sample X4083


title: Ov_Tumor_Reference_Mix vs.  X4078

source_name: Ovarian Cancer Sample X4078


title: Ov_Tumor_Reference_Mix vs.  X4070

source_name: Ovarian Cancer Sample X4070


title: Ov_Tumor_Reference_Mix vs.  X4061

source_name: Ovarian Cancer Sample X4061


title: Ov_Tumor_Reference_Mix vs.  X4076

source_name: Ovarian Cancer Sample X4076


title: Ov_Tumor_Reference_Mix vs.  X4065

source_name: Ovarian Cancer Sample X4065


title: Ov_Tumor_Reference_Mix vs.  X4079

source_name: Ovarian Cancer Sample X4079


title: Ov_Tumor_Reference_Mix vs.  X4071

source_name: Ovarian Cancer Sample X4071


title: Ov_Tumor_Reference_Mix vs.  X4075

source_name: Ovarian Cancer Sample X4075


title: Ov_Tumor_Reference_Mix vs.  X4057

source_name: Ovarian Cancer Sample X4057


title: Ov_Tumor_Reference_Mix vs.  X4059

source_name: Ovarian Cancer Sample X4059


title: Ov_Tumor_Reference_Mix vs.  X4055

source_name: Ovarian Cancer Sample X4055


title: Ov_Tumor_Reference_Mix vs.  X4051

source_name: Ovarian Cancer Sample X4051


title: Ov_Tumor_Reference_Mix vs.  X4053

source_name: 106 pooled ovarian samples

source_name: Ovarian Cancer Sample X4053


title: Ov_Tumor_Reference_Mix vs.  X4047

source_name: Ovarian Cancer Sample X4047


title: Ov_Tumor_Reference_Mix vs.  X4054

source_name: Ovarian Cancer Sample X4054


title: Ov_Tumor_Reference_Mix vs.  X4029

source_name: Ovarian Cancer Sample X4029


title: Ov_Tumor_Reference_Mix vs.  X4044

source_name: Ovarian Cancer Sample X4044


title: Ov_Tumor_Reference_Mix vs.  X4052

source_name: Ovarian Cancer Sample X4052


title: Ov_Tumor_Reference_Mix vs.  X4046

source_name: Ovarian Cancer Sample X4046


title: Ov_Tumor_Reference_Mix vs.  X4043

source_name: Ovarian Cancer Sample X4043


title: Ov_Tumor_Reference_Mix vs.  X4028

source_name: Ovarian Cancer Sample X4028